{"content":"<li class=\"n-box-item date-title\" data-end=\"1553918399\" data-start=\"1553832000\" data-txt=\"Monday, December 23, 2019\">Friday, March 29, 2019</li><li class=\"n-box-item sa-box-item\" data-id=\"3447065\" data-ts=\"1553897485\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AAC\" target=\"_blank\">AAC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3447065-aac-holdings-revises-income-statements-part-of-review\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AAC Holdings revises income statements as part of review</a></h4><ul>   <li>AAC Holdings (NYSE:<a href='https://seekingalpha.com/symbol/AAC' title='AAC Holdings, Inc.'>AAC</a>) is making <a href=\"https://seekingalpha.com/filing/4425623\" target=\"_blank\">preliminary revisions to its income statements</a> over the past few years as part of a fuller review of its restatements.</li>    <li>Changes will increase the company's reported net income for the first three quarters of 2018, by $11.8M. It also will raise net income for 2017 by $14.3M, and lower net income for 2016 by $13.5M.</li>    <li>Those changes aren't due to misconduct, the company says, but rather due to estimates of accounts receivable, provision for doubtful accounts and revenue.</li>    <li>It will result in a cut of about $24.7M to stockholders' equity on its Jan. 1, 2016, balance sheet.</li>    <li>But the changes won't affect previously reported net operating cash flows.</li>    <li>Shares were <font color=\"green\">up 3.3%</font> on very light postmarket trading.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3447065\" data-linked=\"AAC Holdings revises income statements as part of review\" data-tweet=\"$AAC - AAC Holdings revises income statements as part of review https://seekingalpha.com/news/3447065-aac-holdings-revises-income-statements-part-of-review?source=tweet\" data-url=\"https://seekingalpha.com/news/3447065-aac-holdings-revises-income-statements-part-of-review\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:11 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3447060\" data-ts=\"1553896721\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3447060-bldp-adxs-and-bgcp-among-notable-after-hour-movers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BLDP, ADXS and BGCP among notable after hour movers</a></h4><ul><li><b>Top Gainers: </b><a href='https://seekingalpha.com/symbol/BLDP' title='Ballard Power Systems Inc.'>BLDP</a> <font color=\"green\">+4.9. </font><a href='https://seekingalpha.com/symbol/BGCP' title='BGC Partners, Inc.'>BGCP</a> <font color=\"green\">+1.7%. </font><a href='https://seekingalpha.com/symbol/AMRS' title='Amyris, Inc.'>AMRS</a> <font color=\"green\">+1.4%</font>.</li><li><b>Top Losers:</b> <a href='https://seekingalpha.com/symbol/PLAG' title='Planet Green Holdings Corp.'>PLAG</a> <font color=\"red\">-2.9%</font>. <a href='https://seekingalpha.com/symbol/LX' title='LexinFintech Holdings Ltd.'>LX</a> <font color=\"red\">-2.5%</font>. <a href='https://seekingalpha.com/symbol/VNTR' title='Venator Materials PLC'>VNTR</a> <font color=\"red\">-1.3%</font>. <a href='https://seekingalpha.com/symbol/ADXS' title='Advaxis, Inc.'>ADXS</a> <font color=\"red\">-1.3%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3447060\" data-linked=\"BLDP, ADXS and BGCP among notable after hour movers\" data-tweet=\"$BLDP $BGCP $AMRS - BLDP, ADXS and BGCP among notable after hour movers https://seekingalpha.com/news/3447060-bldp-adxs-and-bgcp-among-notable-after-hour-movers?source=tweet\" data-url=\"https://seekingalpha.com/news/3447060-bldp-adxs-and-bgcp-among-notable-after-hour-movers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:58 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3447057\" data-ts=\"1553896228\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MNKD\" target=\"_blank\">MNKD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3447057-mannkind-files-500m-mixed-shelf-warrant-exercise-prospectus\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">MannKind files $500M mixed shelf, warrant exercise prospectus</a></h4><ul>   <li>MannKind (NASDAQ:<a href='https://seekingalpha.com/symbol/MNKD' title='MannKind Corporation'>MNKD</a>) has filed a <a href=\"https://seekingalpha.com/filing/4425525\" target=\"_blank\">$500M mixed shelf registration</a> to offer up to that amount in any combination of common stock, preferred stock, debt securities and warrants.</li>    <li>The filing also has a warrant exercise prospectus to cover up to 26.7M shares.</li>    <li>The warrants covered by that prospectus are the 2018 Common Warrants issued on Dec. 26, exercisable at a price of $1.60 any time before Dec. 26, 2019.</li>    <li>Shares are currently <font color=\"red\">down 2%</font> after hours, to $1.93.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3447057\" data-linked=\"MannKind files $500M mixed shelf, warrant exercise prospectus\" data-tweet=\"$MNKD - MannKind files $500M mixed shelf, warrant exercise prospectus https://seekingalpha.com/news/3447057-mannkind-files-500m-mixed-shelf-warrant-exercise-prospectus?source=tweet\" data-url=\"https://seekingalpha.com/news/3447057-mannkind-files-500m-mixed-shelf-warrant-exercise-prospectus\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:50 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>20&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3447050\" data-ts=\"1553894782\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JAGX\" target=\"_blank\">JAGX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3447050-jaguar-healthplus-10-oasis-discloses-9_99-holding\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Jaguar Health +10% as Oasis discloses 9.99% holding</a></h4><ul>   <li>Jaguar Health (NASDAQ:<a href='https://seekingalpha.com/symbol/JAGX' title='Jaguar Health, Inc.'>JAGX</a>) has <font color=\"green\">jumped 10%</font> on heavy postmarket volume after an SEC filing discloses Oasis Capital <a href=\"https://seekingalpha.com/filing/4424654\" target=\"_blank\">holding a 9.99% stake</a>.</li>    <li>Jaguar had entered into a <a href=\"https://seekingalpha.com/filing/4416480\" target=\"_blank\">securities purchase agreement</a> with Oasis last weekend.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3447050\" data-linked=\"Jaguar Health +10% as Oasis discloses 9.99% holding\" data-tweet=\"$JAGX - Jaguar Health +10% as Oasis discloses 9.99% holding https://seekingalpha.com/news/3447050-jaguar-healthplus-10-oasis-discloses-9_99-holding?source=tweet\" data-url=\"https://seekingalpha.com/news/3447050-jaguar-healthplus-10-oasis-discloses-9_99-holding\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:26 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3447047\" data-ts=\"1553894057\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SCYX\" target=\"_blank\">SCYX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3447047-scynexisminus-4_6-holder-files-to-offer-13m-shares\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Scynexis -4.6% as holder files to offer 13M shares</a></h4><ul>   <li>Scynexis (NASDAQ:<a href='https://seekingalpha.com/symbol/SCYX' title='SCYNEXIS, Inc.'>SCYX</a>) is <font color=\"red\">4.6% lower</font> after hours after a shareholder filing to <a href=\"https://seekingalpha.com/filing/4424896\" target=\"_blank\">offer just over 13M shares</a>.</li>    <li>The shares are issuable pursuant to convertible senior notes that can be converted into that amount of common stock. Those notes were sold by private placement.</li>    <li>The company isn't selling any shares and won't receive any proceeds.</li>    <li>The selling stockholder is Puissance Life Sciences Opportunities, which beneficially owns a 9.99% stake and would exit the holding after the offering.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3447047\" data-linked=\"Scynexis -4.6% as holder files to offer 13M shares\" data-tweet=\"$SCYX - Scynexis -4.6% as holder files to offer 13M shares https://seekingalpha.com/news/3447047-scynexisminus-4_6-holder-files-to-offer-13m-shares?source=tweet\" data-url=\"https://seekingalpha.com/news/3447047-scynexisminus-4_6-holder-files-to-offer-13m-shares\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:14 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3447024\" data-ts=\"1553890921\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AUTL\" target=\"_blank\">AUTL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3447024-autolus-conference-call-april-2-on-car-t-in-all\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Autolus conference call April 2 on CAR T in ALL</a></h4><ul><li>Autolus Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/AUTL' title='Autolus Therapeutics plc'>AUTL</a>) will host a <a href=\"https://seekingalpha.com/pr/17460225-autolus-therapeutics-announces-conference-call-discuss-auto1-allcar19-data-presentation-aacr\" target=\"_blank\">conference call</a> on Tuesday, April 2, at 8:00 am ET to discuss preliminary data from a <a href=\"https://clinicaltrials.gov/ct2/show/NCT02443831\" target=\"_blank\">Phase 1/2 clinical trial</a> evaluating its AUTO1 CD19 CAR T cell therapy in adult patients with acute lymphoblastic leukemia &#40;ALL&#41;.</li><li>The data will presented the day before at AACR in Atlanta.</li><li>Shares are up <font color=\"green\">1%</font> after hours.</li></ul><div class=\"tiny-share-widget\" data-id=\"3447024\" data-linked=\"Autolus conference call April 2 on CAR T in ALL\" data-tweet=\"$AUTL - Autolus conference call April 2 on CAR T in ALL https://seekingalpha.com/news/3447024-autolus-conference-call-april-2-on-car-t-in-all?source=tweet\" data-url=\"https://seekingalpha.com/news/3447024-autolus-conference-call-april-2-on-car-t-in-all\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:22 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3447000\" data-ts=\"1553887770\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CEIX\" target=\"_blank\">CEIX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3447000-consol-energy-raises-borrowing-capacity-cuts-cost-of-capital\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CONSOL Energy raises borrowing capacity, cuts cost of capital</a></h4><ul><li>CONSOL Energy (<a href='https://seekingalpha.com/symbol/CEIX' title='CONSOL Energy Inc.'>CEIX</a> <font color='green'>+1.3%</font>) is higher after saying it negotiated a <a href=\"https://seekingalpha.com/pr/17459514-consol-energy-boosts-liquidity-flexibility-reduces-cost-capital\" target=\"_blank\">$100M increase in its borrowing capacity</a> after revising its revolving credit facilities and its term loan A and B facilities.</li><li>CEIX says the amendment will reduce its cost of capital through lower interest rates, improve financial and operational flexibility through  extended maturity dates and covenant changes, and enhance liquidity.</li><li>The company says the refinancing, its $110M sweep payment on  TLB made in February and $7M of second lien debt repurchase in January will result in a ~$15M overall reduction of annualized interest expense.</li></ul><div class=\"tiny-share-widget\" data-id=\"3447000\" data-linked=\"CONSOL Energy raises borrowing capacity, cuts cost of capital\" data-tweet=\"$CEIX - CONSOL Energy raises borrowing capacity, cuts cost of capital https://seekingalpha.com/news/3447000-consol-energy-raises-borrowing-capacity-cuts-cost-of-capital?source=tweet\" data-url=\"https://seekingalpha.com/news/3447000-consol-energy-raises-borrowing-capacity-cuts-cost-of-capital\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:29 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3446994\" data-ts=\"1553885570\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3446994-progress-software-leads-technology-gainers-dropcar-and-eltek-among-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Progress Software leads technology gainers; DropCar and Eltek among losers</a></h4><ul><li><b>Gainers:</b> Progress Software (NASDAQ:<a href='https://seekingalpha.com/symbol/PRGS' title='Progress Software Corporation'>PRGS</a>) <font color=\"green\">+15%</font>. BlackBerry (NYSE:<a href='https://seekingalpha.com/symbol/BB' title='BlackBerry Limited'>BB</a>) <font color=\"green\">+15%</font>. SITO Mobile (NASDAQ:<a href='https://seekingalpha.com/symbol/SITO' title='SITO Mobile, Ltd.'>SITO</a>) <font color=\"green\">+13%</font>. Autohome (NYSE:<a href='https://seekingalpha.com/symbol/ATHM' title='Autohome Inc.'>ATHM</a>) <font color=\"green\">+13%</font>. Sigma Labs (NASDAQ:<a href='https://seekingalpha.com/symbol/SGLB' title='Sigma Labs, Inc.'>SGLB</a>) <font color=\"green\">+11%</font>.</li><li><b>Losers:</b> Safe-T Group (NASDAQ:<a href='https://seekingalpha.com/symbol/SFET' title='Safe-T Group Ltd'>SFET</a>) <font color=\"red\">-25%</font>. DropCar (NASDAQ:<a href='https://seekingalpha.com/symbol/DCAR' title='DropCar, Inc.'>DCAR</a>) <font color=\"red\">-25%</font>. Eltek (NASDAQ:<a href='https://seekingalpha.com/symbol/ELTK' title='Eltek Ltd.'>ELTK</a>) <font color=\"red\">-21%</font>. SMART Global Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/SGH' title='SMART Global Holdings, Inc.'>SGH</a>) <font color=\"red\">-19%</font>. JMU (NASDAQ:<a href='https://seekingalpha.com/symbol/JMU' title='JMU Limited'>JMU</a>) <font color=\"red\">-11%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3446994\" data-linked=\"Progress Software leads technology gainers; DropCar and Eltek among losers\" data-tweet=\"$PRGS $BB $SITO - Progress Software leads technology gainers; DropCar and Eltek among losers https://seekingalpha.com/news/3446994-progress-software-leads-technology-gainers-dropcar-and-eltek-among-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3446994-progress-software-leads-technology-gainers-dropcar-and-eltek-among-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:52 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3446986\" data-ts=\"1553883169\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OKTA\" target=\"_blank\">OKTA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3446986-okta-top-security-stock-piper-oktaplus-1_5\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Okta a top security stock - Piper; OKTA +1.5%</a></h4><ul><li>Piper Jaffray calls Okta (NASDAQ:<a href='https://seekingalpha.com/symbol/OKTA' title='Okta, Inc.'>OKTA</a>) a top cyber security stock since single sign-on security is \"the top security priority in 2019\" and Okta is the \"pure-play leader in this space.\"</li><li>Rating stays at Overweight with a PT of $89.</li><li>OKTA shares are <font color=\"green\">up 1.5%</font> to $82.51.</li></ul><div class=\"tiny-share-widget\" data-id=\"3446986\" data-linked=\"Okta a top security stock - Piper; OKTA +1.5%\" data-tweet=\"$OKTA - Okta a top security stock - Piper; OKTA +1.5% https://seekingalpha.com/news/3446986-okta-top-security-stock-piper-oktaplus-1_5?source=tweet\" data-url=\"https://seekingalpha.com/news/3446986-okta-top-security-stock-piper-oktaplus-1_5\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:12 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3446981\" data-ts=\"1553882440\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3446981-new-concept-energy-and-nextdecade-among-energy-materials-gainers-senestech-and-hornbeck\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">New Concept Energy and NextDecade among Energy/Materials gainers; SenesTech and Hornbeck Offshore Services among losers</a></h4><ul><li><b>Gainers: </b>New Concept Energy (NYSEMKT:<a href='https://seekingalpha.com/symbol/GBR' title='New Concept Energy, Inc.'>GBR</a>) <font color=\"green\">+35%</font>. NextDecade (NASDAQ:<a href='https://seekingalpha.com/symbol/NEXT' title='NextDecade Corporation'>NEXT</a>) <font color=\"green\">+16%</font>. Mexco Energy (NYSEMKT:<a href='https://seekingalpha.com/symbol/MXC' title='Mexco Energy Corporation'>MXC</a>) <font color=\"green\">+14%</font>. Barnwell Industries (NYSEMKT:<a href='https://seekingalpha.com/symbol/BRN' title='Barnwell Industries, Inc.'>BRN</a>) <font color=\"green\">+12%</font>. Ranger Energy Services (NYSE:<a href='https://seekingalpha.com/symbol/RNGR' title='Ranger Energy Services, Inc.'>RNGR</a>) <font color=\"green\">+9%</font>.</li><li><b>Losers: </b>SenesTech (NASDAQ:<a href='https://seekingalpha.com/symbol/SNES' title='SenesTech, Inc.'>SNES</a>) <font color=\"red\">-10%</font>. Hornbeck Offshore Services (NYSE:<a href='https://seekingalpha.com/symbol/HOS' title='Hornbeck Offshore Services, Inc.'>HOS</a>) <font color=\"red\">-8%</font>. ZK International (NASDAQ:<a href='https://seekingalpha.com/symbol/ZKIN' title='ZK International Group Co., Ltd.'>ZKIN</a>) <font color=\"red\">-7%</font>. Centrus Energy (NYSEMKT:<a href='https://seekingalpha.com/symbol/LEU' title='Centrus Energy Corp.'>LEU</a>) <font color=\"red\">-6%</font>. Key Energy Services (NYSE:<a href='https://seekingalpha.com/symbol/KEG' title='Key Energy Services, Inc.'>KEG</a>) <font color=\"red\">-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3446981\" data-linked=\"New Concept Energy and NextDecade among Energy/Materials gainers; SenesTech and Hornbeck Offshore Services among losers\" data-tweet=\"$GBR $NEXT $MXC - New Concept Energy and NextDecade among Energy/Materials gainers; SenesTech and Hornbeck Offshore Services among losers https://seekingalpha.com/news/3446981-new-concept-energy-and-nextdecade-among-energy-materials-gainers-senestech-and-hornbeck?source=tweet\" data-url=\"https://seekingalpha.com/news/3446981-new-concept-energy-and-nextdecade-among-energy-materials-gainers-senestech-and-hornbeck\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3446979\" data-ts=\"1553881652\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RWLK\" target=\"_blank\">RWLK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3446979-rewalk-reverse-splits-shares-1-25\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ReWalk reverse splits shares 1:25</a></h4><ul><li>ReWalk Robotics (<a href='https://seekingalpha.com/symbol/RWLK' title='ReWalk Robotics Ltd.'>RWLK</a> <font color='red'>-5.7%</font>) has <a href=\"https://seekingalpha.com/pr/17460095-rewalk-robotics-completes-one-twenty-five-reverse-share-split\" target=\"_blank\">completed </a>a 1:25 reverse split of its ordinary shares. Post-split trading will commence on Monday, April 1.</li></ul><div class=\"tiny-share-widget\" data-id=\"3446979\" data-linked=\"ReWalk reverse splits shares 1:25\" data-tweet=\"$RWLK - ReWalk reverse splits shares 1:25 https://seekingalpha.com/news/3446979-rewalk-reverse-splits-shares-1-25?source=tweet\" data-url=\"https://seekingalpha.com/news/3446979-rewalk-reverse-splits-shares-1-25\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:47 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3446973\" data-ts=\"1553879689\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SITO\" target=\"_blank\">SITO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3446973-sito-mobileplus-9-post-q4-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">SITO Mobile +9% post Q4 results</a></h4><div><ul><li>SITO Mobile (<a href='https://seekingalpha.com/symbol/SITO' title='SITO Mobile, Ltd.'>SITO</a> <font color=\"green\">+9.8%</font>) reports Q4 revenue decrease of 24.4% to $11.12M, due to a reduction in the average spending per customer.</li><li>Q4 Gross margin <font color=\"green\">improved by 390 bps</font> to 50.3%, reflecting higher gross margins in new client engagements.</li><li>Loss from operations reduced to $1.27M from $6.93M a year ago. The decrease was due to an overall decrease in office and employee compensation expense.</li><li>Q4 Adj. EBITDA was $145.5k, compared to loss of $1.97M last year same quarter.</li><li>Company has cash and cash equivalents of $2.6M, as of December 31, 2018.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3446810-sito-mobile-beats-0_05-misses-revenue\" target=\"_blank\">SITO Mobile beats by $0.05, misses on revenue</a> (March 29)</li></ul></div><div class=\"tiny-share-widget\" data-id=\"3446973\" data-linked=\"SITO Mobile +9% post Q4 results\" data-tweet=\"$SITO - SITO Mobile +9% post Q4 results https://seekingalpha.com/news/3446973-sito-mobileplus-9-post-q4-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3446973-sito-mobileplus-9-post-q4-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:14 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3446970\" data-ts=\"1553879138\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3446970-eagle-materials-leads-industrial-gainers-hovnanian-enterprises-and-highpower-international\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Eagle Materials leads industrial gainers; Hovnanian Enterprises and Highpower International among losers</a></h4><ul><li><b>Gainers: </b>Eagle Materials (NYSE:<a href='https://seekingalpha.com/symbol/EXP' title='Eagle Materials Inc.'>EXP</a>) <font color=\"green\">+13%</font>. IntriCon (NASDAQ:<a href='https://seekingalpha.com/symbol/IIN' title='IntriCon Corporation'>IIN</a>) <font color=\"green\">+11%</font>. Limbach Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/LMB' title='Limbach Holdings, Inc.'>LMB</a>) <font color=\"green\">+6%</font>.</li><li><b>Losers: </b>Euro Tech Holdings Company (NASDAQ:<a href='https://seekingalpha.com/symbol/CLWT' title='Euro Tech Holdings Company Limited'>CLWT</a>) <font color=\"red\">-17%</font>. Hovnanian Enterprises (NYSE:<a href='https://seekingalpha.com/symbol/HOV' title='Hovnanian Enterprises, Inc.'>HOV</a>) <font color=\"red\">-14%</font>. NF Energy Saving (NASDAQ:<a href='https://seekingalpha.com/symbol/BIMI' title='NF Energy Saving Corporation'>BIMI</a>) <font color=\"red\">-12%</font>. China Advanced Construction Materials Group (NASDAQ:<a href='https://seekingalpha.com/symbol/CADC' title='China Advanced Construction Materials Group, Inc.'>CADC</a>) <font color=\"red\">-11%</font>. Highpower International (NASDAQ:<a href='https://seekingalpha.com/symbol/HPJ' title='Highpower International, Inc.'>HPJ</a>) <font color=\"red\">-8%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3446970\" data-linked=\"Eagle Materials leads industrial gainers; Hovnanian Enterprises and Highpower International among losers\" data-tweet=\"$EXP $IIN $LMB - Eagle Materials leads industrial gainers; Hovnanian Enterprises and Highpower International among losers https://seekingalpha.com/news/3446970-eagle-materials-leads-industrial-gainers-hovnanian-enterprises-and-highpower-international?source=tweet\" data-url=\"https://seekingalpha.com/news/3446970-eagle-materials-leads-industrial-gainers-hovnanian-enterprises-and-highpower-international\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:05 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3446971\" data-ts=\"1553879129\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3446971-hexindai-leads-financial-gainers-carver-bancorp-and-medley-management-among-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Hexindai leads financial gainers; Carver Bancorp and Medley Management among losers</a></h4><ul><li><b>Gainers:</b> Hexindai Inc. (NASDAQ:<a href='https://seekingalpha.com/symbol/HX' title='Hexindai Inc.'>HX</a>) <font color=\"green\">+14%</font>. Wheeler Real Estate Investment Trust Inc. (NASDAQ:<a href='https://seekingalpha.com/symbol/WHLRP' title='Wheeler Real Estate Investment Trust, Inc.'>WHLRP</a>) <font color=\"green\">+10%</font>. Noah Holdings (NYSE:<a href='https://seekingalpha.com/symbol/NOAH' title='Noah Holdings Limited'>NOAH</a>) <font color=\"green\">+7%</font>.</li><li><b>Losers:</b> Carver Bancorp (NASDAQ:<a href='https://seekingalpha.com/symbol/CARV' title='Carver Bancorp, Inc.'>CARV</a>) <font color=\"red\">-10%</font>. Medley Management (NYSE:<a href='https://seekingalpha.com/symbol/MDLY' title='Medley Management Inc.'>MDLY</a>) <font color=\"red\">-10%</font>. China Internet Nationwide Financial Services (NASDAQ:<a href='https://seekingalpha.com/symbol/CIFS' title='China Internet Nationwide Financial Services Inc.'>CIFS</a>) <font color=\"red\">-10%</font>. Wheeler Real Estate Investment Trust (NASDAQ:<a href='https://seekingalpha.com/symbol/WHLR' title='Wheeler Real Estate Investment Trust, Inc.'>WHLR</a>) <font color=\"red\">-8%</font>. CBL &amp; Associates Properties (NYSE:<a href='https://seekingalpha.com/symbol/CBL' title='CBL & Associates Properties, Inc'>CBL</a>) <font color=\"red\">-8%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3446971\" data-linked=\"Hexindai leads financial gainers; Carver Bancorp and Medley Management among losers\" data-tweet=\"$HX $WHLRP $NOAH - Hexindai leads financial gainers; Carver Bancorp and Medley Management among losers https://seekingalpha.com/news/3446971-hexindai-leads-financial-gainers-carver-bancorp-and-medley-management-among-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3446971-hexindai-leads-financial-gainers-carver-bancorp-and-medley-management-among-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:05 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3446967\" data-ts=\"1553878719\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VLO\" target=\"_blank\">VLO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3446967-valero-energy-sued-for-selling-bad-marine-fuel\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Valero Energy sued for selling bad marine fuel</a></h4><ul><li>Two companies filled lawsuits this week in federal courts in Texas alleging that ships they operated in 2018 were <a href=\"https://www.reuters.com/article/us-energy-lawsuit-valero/companies-sue-valero-for-bad-marine-fuel-idUSKCN1RA1VD\" target=\"_blank\">damaged by contaminated bunker fuel</a> sold by refiner Valero Energy (<a href='https://seekingalpha.com/symbol/VLO' title='Valero Energy Corporation'>VLO</a>).</li><li>A Saudi Arabian shipping firm said it paid out $1.1M for repairs and replacement fuel for a ship that drifted at sea for two days before restarting and arriving in Egypt for repairs in May 2018, Reuters reports, citing court documents.</li><li>A Mexican petrochemical company said in court documents that VLO knew early that there were problems with the bunker fuel that affected more than 150 ships during H1 2018.</li></ul><div class=\"tiny-share-widget\" data-id=\"3446967\" data-linked=\"Valero Energy sued for selling bad marine fuel\" data-tweet=\"$VLO - Valero Energy sued for selling bad marine fuel https://seekingalpha.com/news/3446967-valero-energy-sued-for-selling-bad-marine-fuel?source=tweet\" data-url=\"https://seekingalpha.com/news/3446967-valero-energy-sued-for-selling-bad-marine-fuel\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:58 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3446964\" data-ts=\"1553878186\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LNG\" target=\"_blank\">LNG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3446964-cheniere-energy-says-lng-deals-china-are-on-ice-ft\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cheniere Energy says LNG deals with China are on ice - FT</a></h4><ul><li>A Cheniere Energy (<a href='https://seekingalpha.com/symbol/LNG' title='Cheniere Energy, Inc.'>LNG</a> <font color='green'>+2.9%</font>) executive tells the <em>Financial Times</em> that <a href=\"https://www.ft.com/content/bfcbbf5a-5178-11e9-9c76-bf4a0ce37d49\" target=\"_blank\">deals with China for liquefied natural gas are on hold</a> until the trade dispute with the U.S. is resolved.</li><li>Pres. Trump is \"definitely making some headwinds for us to sell long-term contracts to China,\" says managing director of commercial operations Eric Bensaude, as would-be Chinese buyers \"have received instructions not to enter into more transactions.\"</li><li>But Bensaude also says he is optimistic that the trade standoff will be resolved, and that LNG likely would be part of any deal to improve bilateral relations and help \"reducing the trade imbalance between the two countries.\"</li><li>Cheniere signed the first long-term supply deal - a 25-year contract - with China last year, for 1.2M mt/year of LNG to China National Petroleum Corp.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/UNG' title='The United States Natural Gas ETF, LP'>UNG</a>, <a href='https://seekingalpha.com/symbol/UGAZ' title='VelocityShares 3x Long Natural Gas ETN'>UGAZ</a>, <a href='https://seekingalpha.com/symbol/DGAZ' title='VelocityShares 3x Inverse Natural Gas ETN'>DGAZ</a>, <a href='https://seekingalpha.com/symbol/BOIL' title='ProShares Ultra Bloomberg Natural Gas ETF'>BOIL</a>, <a href='https://seekingalpha.com/symbol/KOLD' title='ProShares UltraShort Bloomberg Natural Gas ETF'>KOLD</a>, <a href='https://seekingalpha.com/symbol/UNL' title='The United States 12 Month Natural Gas ETF, LP'>UNL</a>, <a href='https://seekingalpha.com/symbol/GAZB' title='iPath Series B Bloomberg Natural Gas Subindex Total Return ETN'>GAZB</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3446964\" data-linked=\"Cheniere Energy says LNG deals with China are on ice - FT\" data-tweet=\"$LNG $UNG $UGAZ - Cheniere Energy says LNG deals with China are on ice - FT https://seekingalpha.com/news/3446964-cheniere-energy-says-lng-deals-china-are-on-ice-ft?source=tweet\" data-url=\"https://seekingalpha.com/news/3446964-cheniere-energy-says-lng-deals-china-are-on-ice-ft\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:49 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>32&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3446962\" data-ts=\"1553878133\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3446962-midday-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers</a></h4><ul><li><strong>Gainers: </strong>New Concept Energy (NYSEMKT:<a href='https://seekingalpha.com/symbol/GBR' title='New Concept Energy, Inc.'>GBR</a>) <font color=\"green\">+45%</font>. Estre Ambiental (NASDAQ:<a href='https://seekingalpha.com/symbol/ESTR' title='Estre Ambiental, Inc.'>ESTR</a>) <font color=\"green\">+38%</font>. Chicken Soup for the Soul Entertainment (NASDAQ:<a href='https://seekingalpha.com/symbol/CSSE' title='Chicken Soup for the Soul Entertainment, Inc.'>CSSE</a>) <font color=\"green\">+22%</font>. Galapagos (NASDAQ:<a href='https://seekingalpha.com/symbol/GLPG' title='Galapagos NV'>GLPG</a>) <font color=\"green\">+22%</font>. Seelos Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/SEEL' title='Seelos Therapeutics, Inc.'>SEEL</a>) <font color=\"green\">+21%</font>. Boxlight (NASDAQ:<a href='https://seekingalpha.com/symbol/BOXL' title='Boxlight Corporation'>BOXL</a>) <font color=\"green\">+20%</font>. Iconix Brand Group (NASDAQ:<a href='https://seekingalpha.com/symbol/ICON' title='Iconix Brand Group, Inc.'>ICON</a>) <font color=\"green\">+18%</font>. Progress Software (NASDAQ:<a href='https://seekingalpha.com/symbol/PRGS' title='Progress Software Corporation'>PRGS</a>) <font color=\"green\">+16%</font>. NextDecade (NASDAQ:<a href='https://seekingalpha.com/symbol/NEXT' title='NextDecade Corporation'>NEXT</a>) <font color=\"green\">+15%</font>. BlackBerry (NYSE:<a href='https://seekingalpha.com/symbol/BB' title='BlackBerry Limited'>BB</a>) <font color=\"green\">+14%</font>.</li><li><strong>Losers: </strong>ENDRA Life Sciences (NASDAQ:<a href='https://seekingalpha.com/symbol/NDRA' title='ENDRA Life Sciences Inc.'>NDRA</a>) <font color=\"red\">-40%</font>. DropCar (NASDAQ:<a href='https://seekingalpha.com/symbol/DCAR' title='DropCar, Inc.'>DCAR</a>) <font color=\"red\">-26%</font>. Safe-T Group (NASDAQ:<a href='https://seekingalpha.com/symbol/SFET' title='Safe-T Group Ltd'>SFET</a>) <font color=\"red\">-24%</font>. SMART Global Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/SGH' title='SMART Global Holdings, Inc.'>SGH</a>) <font color=\"red\">-21%</font>. RH (NYSE:<a href='https://seekingalpha.com/symbol/RH' title='RH'>RH</a>) <font color=\"red\">-20%</font>. Reebonz Holding (NASDAQ:<a href='https://seekingalpha.com/symbol/RBZ' title='Reebonz Holding Limited'>RBZ</a>) <font color=\"red\">-20%</font>. Eltek (NASDAQ:<a href='https://seekingalpha.com/symbol/ELTK' title='Eltek Ltd.'>ELTK</a>) <font color=\"red\">-19%</font>. Euro Tech Holdings Company (NASDAQ:<a href='https://seekingalpha.com/symbol/CLWT' title='Euro Tech Holdings Company Limited'>CLWT</a>) <font color=\"red\">-18%</font>. XpresSpa Group (NASDAQ:<a href='https://seekingalpha.com/symbol/XSPA' title='XpresSpa Group, Inc.'>XSPA</a>) <font color=\"red\">-18%</font>. Tyme Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/TYME' title='Tyme Technologies, Inc.'>TYME</a>) <font color=\"red\">-15%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3446962\" data-linked=\"Midday Gainers / Losers\" data-tweet=\"$GBR $ESTR $CSSE - Midday Gainers / Losers https://seekingalpha.com/news/3446962-midday-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3446962-midday-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:48 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3446963\" data-ts=\"1553878110\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3446963-vivendi-backs-off-from-telecom-italia-fight-withdrawing-slate\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Vivendi backs off from Telecom Italia fight, withdrawing slate</a></h4><ul>   <li>Vivendi (<a href=\"http://seekingalpha.com/symbol/VIVHY\" target=\"_blank\">VIVHY</a> <font color=\"red\">-0.2%</font>) has <a href=\"https://www.nasdaq.com/article/vivendi-ready-to-drop-request-to-replace-telecom-italia-board-members-20190329-00478\" target=\"_blank\">backed down in a stand-off</a> with Elliott Management over control of Telecom Italia (<a href=\"http://seekingalpha.com/symbol/TI\" target=\"_blank\">TI</a> <font color=\"green\">+2.3%</font>), the incumbent firm that Elliott started managing after taking control of the board last spring.</li>    <li>At the last minute, Vivendi offered to withdraw its challenge slate (though it was seen as losing the vote to remove five Elliott-backed members, and had major proxy advisory services <a href=\"https://seekingalpha.com/news/3442577-glass-lewis-joins-iss-opposing-vivendi-telecom-italia-vote\" target=\"_blank\">throwing their support to Elliott</a> in the fight).</li>    <li>\"We have decided not to pursue today our proposal to revoke and replace five board members provided that this has the support of this shareholder meeting,\" Vivendi's Caroline Le Masne De Chermont told the meeting.</li>    <li>That's \u201cthe first step to set up new collaborative relations between the shareholders,\u201d TI CEO Luigi Gubitosi says. He adds that talks with Open Fiber on a potential deal are still ongoing, and the company expects to have better results by the end of the year.</li>    <li>Italian state lender Cassa Depositi e Prestiti recently became the second-biggest shareholder of TI behind Vivendi, and could act as a peacemaker between the factions.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3443344-vivendi-takes-aim-elliott-telecom-italia-fight\" target=\"_blank\">Vivendi again takes aim at Elliott in Telecom Italia fight</a> (Mar. 15 2019)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3441903-telecom-italia-minus-4_7-percent-board-tension-ratchets\" target=\"_blank\">Telecom Italia -4.7% as board tension ratchets up</a> (Mar. 12 2019)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3446963\" data-linked=\"Vivendi backs off from Telecom Italia fight, withdrawing slate\" data-tweet=\"$VIVHY $TI - Vivendi backs off from Telecom Italia fight, withdrawing slate https://seekingalpha.com/news/3446963-vivendi-backs-off-from-telecom-italia-fight-withdrawing-slate?source=tweet\" data-url=\"https://seekingalpha.com/news/3446963-vivendi-backs-off-from-telecom-italia-fight-withdrawing-slate\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:48 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3446951\" data-ts=\"1553876566\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BMY\" target=\"_blank\">BMY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3446951-starboard-pulls-out-of-celgene-fight\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Starboard pulls out of Celgene fight</a></h4><ul><li>Conceding dim chances that its opposition to Bristol-Myers Squibb's (<a href='https://seekingalpha.com/symbol/BMY' title='Bristol-Myers Squibb Company'>BMY</a> <font color=\"red\">-1.5%</font>) $74B takeover of Celgene (<a href='https://seekingalpha.com/symbol/CELG' title='Celgene Corporation'>CELG</a> <font color=\"green\">+7.2%</font>) will prevail after ISS blessed the deal, Starboard Value has <a href=\"https://seekingalpha.com/pr/17459999-starboard-issues-statement-bristol-myers\" target=\"_blank\">withdrawn its proxy solicitation</a> seeking nay votes.</li><li>The companies' stockholders will vote on the marriage on April 12, now looking certain to pass.</li></ul><div class=\"tiny-share-widget\" data-id=\"3446951\" data-linked=\"Starboard pulls out of Celgene fight\" data-tweet=\"$BMY $CELG - Starboard pulls out of Celgene fight https://seekingalpha.com/news/3446951-starboard-pulls-out-of-celgene-fight?source=tweet\" data-url=\"https://seekingalpha.com/news/3446951-starboard-pulls-out-of-celgene-fight\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:22 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>67&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3446950\" data-ts=\"1553876409\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ETSY\" target=\"_blank\">ETSY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3446950-oppenheimer-coolish-on-etsy-due-to-valuation\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Oppenheimer coolish on Etsy due to valuation</a></h4><ul> <li>Oppenheimer initiates coverage on Etsy (<a href='https://seekingalpha.com/symbol/ETSY' title='Etsy, Inc.'>ETSY</a> <font color='green'>+0.3%</font>) with a Market Perform rating.</li> <li>\"We struggle to justify the premium valuation at 8.1x '20E sales vs. peers at 4.7x, while \u201918-\u201920E sales CAGR is comparable to peers at 27%,\" writes the Oppenheimer analyst team in its first look at the e-commerce retailer.</li> <li>Digging into the numbers a bit more, Oppenheimer notes Etsy management guided long-term EBITDA margins to the \"high 20's and low 30's\" - yet shares imply margins widen to 33% long term.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3446950\" data-linked=\"Oppenheimer coolish on Etsy due to valuation\" data-tweet=\"$ETSY - Oppenheimer coolish on Etsy due to valuation https://seekingalpha.com/news/3446950-oppenheimer-coolish-on-etsy-due-to-valuation?source=tweet\" data-url=\"https://seekingalpha.com/news/3446950-oppenheimer-coolish-on-etsy-due-to-valuation\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:20 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3446948\" data-ts=\"1553876329\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LITB\" target=\"_blank\">LITB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3446948-on-lightintheboxs-q4-results-shares-up-7\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on LightInTheBox&#39;s Q4 results; shares up 7%</a></h4><div><ul><li>LightInTheBox (<a href='https://seekingalpha.com/symbol/LITB' title='LightInTheBox Holding Co., Ltd.'>LITB</a> <font color=\"green\">+7.2%</font>) reported Q4 revenue decrease of 37.2% Y/Y to $57.54M, with Product sales of $83.14M (-33.3% Y/Y); and Services &amp; other $8.47M (-75.5% Y/Y).</li><li>Total orders of product sales were 1.3M, compared with 1.7M in Q4 2017; and total number of customers for product sales was 1M compared with 1.4M in Q4 2017.</li><li>Q4 Gross margin <font color=\"green\">improved by 495 bps</font> to 34.6%.</li><li>Loss from operations reduced to $1.7M, compare to $3.6M same quarter last year.</li><li>Q4 Operating expenses: Fulfilment $3.5M (-29.4% Y/Y); selling &amp; marketing $11.79M (-33.6% Y/Y); and G&amp;A $6.25M (-21.7% Y/Y).</li><li>Company generated positive cash flow with cash and cash equivalents of $38.8M as of December 31, 2018.</li><li><strong>1Q19 Outlook: </strong>Net revenues to be between $48M and $51M.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3446807-lightinthebox-reports-q4-results\" target=\"_blank\">LightInTheBox reports Q4 results</a> (March 29)</li></ul></div><div class=\"tiny-share-widget\" data-id=\"3446948\" data-linked=\"More on LightInTheBox&#39;s Q4 results; shares up 7%\" data-tweet=\"$LITB - More on LightInTheBox&#39;s Q4 results; shares up 7% https://seekingalpha.com/news/3446948-on-lightintheboxs-q4-results-shares-up-7?source=tweet\" data-url=\"https://seekingalpha.com/news/3446948-on-lightintheboxs-q4-results-shares-up-7\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:18 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3446946\" data-ts=\"1553875888\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KN\" target=\"_blank\">KN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3446946-knowlesplus-2-on-shareholder-letter-to-board\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Knowles +2% on shareholder letter to board</a></h4><ul><li>Caligan Partners and Falcon Edge Capital <a href=\"https://seekingalpha.com/pr/17459809-caligan-partners-falcon-edge-capital-send-letter-board-directors-knowles-corp\" target=\"_blank\">send a letter</a> to the Knowles (NYSE:<a href='https://seekingalpha.com/symbol/KN' title='Knowles Corporation'>KN</a>) board asking for more information about the Intelligent Audio segment, conduct a strategic review of the Precision Devices segment, and make changes to the board.</li><li>The duo manages funds that own an over 6.7% stake and want Knowles to \"address the root causes of its significant underperformance.\" Doing so, the holders say, could lead Knowles to be valued at more than $28 per share.</li><li>Knowles shares are <font color=\"green\">up 2%</font> to $17.24.</li></ul><div class=\"tiny-share-widget\" data-id=\"3446946\" data-linked=\"Knowles +2% on shareholder letter to board\" data-tweet=\"$KN - Knowles +2% on shareholder letter to board https://seekingalpha.com/news/3446946-knowlesplus-2-on-shareholder-letter-to-board?source=tweet\" data-url=\"https://seekingalpha.com/news/3446946-knowlesplus-2-on-shareholder-letter-to-board\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:11 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3446943\" data-ts=\"1553875200\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NROM\" target=\"_blank\">NROM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3446943-noble-romanplus-4_4-post-q4-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Noble Roman +4.4% post Q4 results</a></h4><ul><li>Noble Roman (<a href='https://seekingalpha.com/symbol/NROM' title='Noble Roman&#39;s, Inc.'>OTCQB:NROM</a> <font color=\"green\">+4.4%</font>) reports <a href=\"https://seekingalpha.com/pr/17457377-noble-romans-announces-2018-results-reports-adjusted-net-income-nearly-70-percent-discusses\" target=\"_blank\">Q4</a> revenue growth of 15.4% Y/Y to $3M.</li><li>Royalties and fees revenue were ~ $1.7M (flat Y/Y); Restaurant revenue from Craft Pizza &amp; Pub increased 100% Y/Y to $1.2M &amp; Restaurant revenue from non-traditional, company-owned locations decreased 3.3% to $294K.</li><li>Franchise related operating expenses increased 7.3% Y/Y to $620K.</li><li>Adj. EBITDA was $3.4M (+6.3% Y/Y).</li><li>From January 1 to March 26, 2019 the company has signed 14 new franchise/license agreements.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3446248-noble-romans-reports-q4-results\" target=\"_blank\">Noble Roman's reports Q4 results</a> (Mar. 27 2019)</li></ul><div class=\"tiny-share-widget\" data-id=\"3446943\" data-linked=\"Noble Roman +4.4% post Q4 results\" data-tweet=\"$NROM - Noble Roman +4.4% post Q4 results https://seekingalpha.com/news/3446943-noble-romanplus-4_4-post-q4-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3446943-noble-romanplus-4_4-post-q4-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3446942\" data-ts=\"1553875182\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3446942-iconix-brand-group-only-consumer-gainer-movado-group-leads-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Iconix Brand Group only consumer gainer; Movado Group leads the losers</a></h4><ul><li><b>Gainers: </b>Iconix Brand Group (NASDAQ:<a href='https://seekingalpha.com/symbol/ICON' title='Iconix Brand Group, Inc.'>ICON</a>) <font color=\"green\">+11%</font>.</li><li><b>Losers: </b>Movado Group (NYSE:<a href='https://seekingalpha.com/symbol/MOV' title='Movado Group, Inc.'>MOV</a>) <font color=\"red\">-9%</font>. YETI Holdings (NYSE:<a href='https://seekingalpha.com/symbol/YETI' title='YETI Holdings, Inc.'>YETI</a>) <font color=\"red\">-9%</font>. Planet Green Holdings (NYSEMKT:<a href='https://seekingalpha.com/symbol/PLAG' title='Planet Green Holdings Corp.'>PLAG</a>) <font color=\"red\">-7%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3446942\" data-linked=\"Iconix Brand Group only consumer gainer; Movado Group leads the losers\" data-tweet=\"$ICON $MOV $YETI - Iconix Brand Group only consumer gainer; Movado Group leads the losers https://seekingalpha.com/news/3446942-iconix-brand-group-only-consumer-gainer-movado-group-leads-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3446942-iconix-brand-group-only-consumer-gainer-movado-group-leads-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:59 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3446939\" data-ts=\"1553874425\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LYFT\" target=\"_blank\">LYFT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3446939-lyft-opens-first-day-up-21\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Lyft opens first day up 21%</a></h4><ul><li><strong>Update:</strong> Lyft opens at $87.24, <font color=\"green\">up 21%</font>.</li><li>Lyft (NASDAQ:<a href='https://seekingalpha.com/symbol/LYFT' title='Lyft, Inc.'>LYFT</a>) is indicated to open its first day of trading <font color=\"green\">up 19% </font>to $86.</li><li>Yesterday, Lyft <a href=\"https://seekingalpha.com/news/3446705-lyft-prices-ipo-72-share\" target=\"_blank\">priced</a> the IPO at $72/share for a fully-diluted market valuation of $24B.</li></ul><div class=\"tiny-share-widget\" data-id=\"3446939\" data-linked=\"Lyft opens first day up 21%\" data-tweet=\"$LYFT - Lyft opens first day up 21% https://seekingalpha.com/news/3446939-lyft-opens-first-day-up-21?source=tweet\" data-url=\"https://seekingalpha.com/news/3446939-lyft-opens-first-day-up-21\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:47 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>157&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3446929\" data-ts=\"1553872630\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SAIC\" target=\"_blank\">SAIC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3446929-science-applications-raised-after-ugliest-quarter\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Science Applications raised after &#39;ugliest&#39; quarter</a></h4><ul><li>Vertical Research upgrades Science Applications (NYSE:<a href='https://seekingalpha.com/symbol/SAIC' title='Science Applications International Corporation'>SAIC</a>) from Hold to Buy saying the \"ugliest potential quarter\" is over and \"sailing should be much smoother going forward.\"</li><li>The firm now expects SAIC to focus on aggressive share repurchasing, which will drive \"tremendous growth\" in FCF per share in the next two years.</li><li>SAIC shares are <font color=\"green\">up 6.8%</font> to $78.51.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3446899-science-applications-plus-6-percent-q4-earnings-beat\" target=\"_blank\">Science Applications +6% on Q4 earnings beat</a> (March 29)</li></ul><div class=\"tiny-share-widget\" data-id=\"3446929\" data-linked=\"Science Applications raised after &#39;ugliest&#39; quarter\" data-tweet=\"$SAIC - Science Applications raised after &#39;ugliest&#39; quarter https://seekingalpha.com/news/3446929-science-applications-raised-after-ugliest-quarter?source=tweet\" data-url=\"https://seekingalpha.com/news/3446929-science-applications-raised-after-ugliest-quarter\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:17 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3446927\" data-ts=\"1553872335\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CREX\" target=\"_blank\">CREX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3446927-creative-realities-down-8-post-q4-revenue-miss\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Creative Realities down 8% post Q4 revenue miss</a></h4><div><ul><li>Creative Realities (<a href='https://seekingalpha.com/symbol/CREX' title='Creative Realities, Inc.'>CREX</a> <font color=\"red\">-8.8%</font>) revenues for Q4 increased by 26% Y/Y to $5.2M, and organic revenues +12% Y/Y.</li><li>Q4 Service revenues represented ~73% of total revenue compared to 58% in 2017.</li><li>Q4 Gross profit increased by 26% Y/Y to $1.9M; and gross margin was flat at 36%.</li><li>Operating loss was $2.1M, compared to $1.6M a year ago; and Adj. operating loss was $1.1M.</li><li>Company mentioned they entered 2019 with ~$18M in signed orders and believe the combined sales organization has strong forward momentum.</li><li><strong>1H19 Guidance:</strong> Revenues in the range of $18M to $20M; and anticipated revenue from new customers in excess of $3M.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3446706-creative-realities-misses-revenue\" target=\"_blank\">Creative Realities misses on revenue</a> (March 28)</li></ul></div><div class=\"tiny-share-widget\" data-id=\"3446927\" data-linked=\"Creative Realities down 8% post Q4 revenue miss\" data-tweet=\"$CREX - Creative Realities down 8% post Q4 revenue miss https://seekingalpha.com/news/3446927-creative-realities-down-8-post-q4-revenue-miss?source=tweet\" data-url=\"https://seekingalpha.com/news/3446927-creative-realities-down-8-post-q4-revenue-miss\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:12 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3446925\" data-ts=\"1553872084\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3446925-states-pursuing-independent-review-of-t-mobile-sprint-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">States pursuing independent review of T-Mobile/Sprint deal</a></h4><ul>   <li>U.S. states are examining T-Mobile's (<a href=\"http://seekingalpha.com/symbol/TMUS\" target=\"_blank\">TMUS</a> <font color=\"red\">-0.8%</font>) $26.5B acquisition of Sprint (<a href=\"http://seekingalpha.com/symbol/S\" target=\"_blank\">S</a> <font color=\"red\">-2.2%</font>) as an independent review, says the chair of the Multistate Antitrust Task Force for the National Association of Attorneys General.</li>    <li>Shares in the companies have been under pressure over the past few days alongside news of <a href=\"https://seekingalpha.com/news/3446525-skepticism-sprint-argues-weak-without-t-mobile\" target=\"_blank\">skepticism in the regulatory ranks</a> and states <a href=\"https://seekingalpha.com/news/3446702-reports-states-consider-suit-block-t-mobiles-sprint-acquisition\" target=\"_blank\">considering a lawsuit</a> to block the deal.</li>    <li>Speaking at the American Bar Association, Sarah Oxenham Allen says states are acting separately from the federal government in part due to the impact of the deal on urban and rural areas. The state group is coordinating with the Justice Dept. and FCC, however, she says. (h/t Bloomberg)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3446925\" data-linked=\"States pursuing independent review of T-Mobile/Sprint deal\" data-tweet=\"$TMUS $S - States pursuing independent review of T-Mobile/Sprint deal https://seekingalpha.com/news/3446925-states-pursuing-independent-review-of-t-mobile-sprint-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/3446925-states-pursuing-independent-review-of-t-mobile-sprint-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:08 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>30&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3446924\" data-ts=\"1553871984\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IZEA\" target=\"_blank\">IZEA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3446924-izea-worldwide-slides-10_5-post-q4-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">IZEA Worldwide slides 10.5% post Q4 results</a></h4><ul><li>IZEA Worldwide (<a href='https://seekingalpha.com/symbol/IZEA' title='IZEA Worldwide, Inc.'>IZEA</a> <font color=\"red\">-10.5%</font>) reports <a href=\"https://seekingalpha.com/pr/17459063-izea-reports-q4-fy2018-financial-results\" target=\"_blank\">Q4</a> revenue decrease of 7.4% Y/Y to $6.3M.</li><li>Managed Services revenue decreased 25% Y/Y to $4.9M &amp; SaaS Services revenue increased 1,588% Y/Y to $1.4M.</li><li>Gross billings up 42% Y/Y to $11.1M &amp; Bookings increased 115% Y/Y to $11.2M.</li><li>Total costs &amp; expenses reduced by 9.3% Y/Y to $6.8M; decrease was primarily due to decreased personnel-related costs as well as lower public relations and marketing expenses.</li><li>Adj. EBITDA was $23K (-77.7% Y/Y).</li><li>Cash and equivalents totaled $2M also, at the end of the quarter the Company had accessed ~$1.5M of its $5M credit line.</li><li>The company completed acquisition of TapInfluence and launched VizSearch Discovery Tool, UnityRank, and Discovered Demographics.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3446630-izea-worldwide-beats-0_01-misses-revenue\" target=\"_blank\">IZEA Worldwide beats by $0.01, misses on revenue</a> (Mar. 28 2019)</li></ul><div class=\"tiny-share-widget\" data-id=\"3446924\" data-linked=\"IZEA Worldwide slides 10.5% post Q4 results\" data-tweet=\"$IZEA - IZEA Worldwide slides 10.5% post Q4 results https://seekingalpha.com/news/3446924-izea-worldwide-slides-10_5-post-q4-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3446924-izea-worldwide-slides-10_5-post-q4-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:06 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3446921\" data-ts=\"1553871804\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IPCI\" target=\"_blank\">IPCI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3446921-intellipharmaceutics-up-16-on-second-try-oxycodone\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Intellipharmaceutics up 16% on second try with oxycodone</a></h4><ul><li>Nano cap Intellipharmaceutics (<a href='https://seekingalpha.com/symbol/IPCI' title='Intellipharmaceutics International Inc.'>IPCI</a> <font color=\"green\">+16.1%</font>) is up on double normal volume after <a href=\"https://seekingalpha.com/news/3297270-intellipharmaceutics-receives-crl-fda-regarding-rexista-marketing-application\" target=\"_blank\">announcing </a>the FDA's acceptance of its resubmitted marketing application seeking approval for opioid painkiller Rexista (oxycodone hydrochloride extended-release). The agency's action date is August 28.</li><li>The FDA <a href=\"https://seekingalpha.com/news/3297270-intellipharmaceutics-receives-crl-fda-regarding-rexista-marketing-application\" target=\"_blank\">rejected </a>its initial filing in September 2017 citing the need for more data on the drug's abuse potential by oral and nasal routes and more information on the abuse-deterrent blue dye in the formulation.</li><li>The company cautions that the agency may still require additional studies, certainly a possibility considering Commissioner Gottlieb's recent comments about the need for a <a href=\"https://seekingalpha.com/news/3446688-fdas-gottlieb-proposes-higher-standard-future-opioid-approvals\" target=\"_blank\">higher standard</a> of approval for opioids.</li></ul><div class=\"tiny-share-widget\" data-id=\"3446921\" data-linked=\"Intellipharmaceutics up 16% on second try with oxycodone\" data-tweet=\"$IPCI - Intellipharmaceutics up 16% on second try with oxycodone https://seekingalpha.com/news/3446921-intellipharmaceutics-up-16-on-second-try-oxycodone?source=tweet\" data-url=\"https://seekingalpha.com/news/3446921-intellipharmaceutics-up-16-on-second-try-oxycodone\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:03 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3446923\" data-ts=\"1553871787\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3446923-seelos-therapeutics-leads-healthcare-gainers-vermillion-and-chiasma-among-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Seelos Therapeutics leads healthcare gainers; Vermillion and Chiasma among the losers</a></h4><ul><li><b>Gainers: </b>Seelos Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/SEEL' title='Seelos Therapeutics, Inc.'>SEEL</a>) <font color=\"green\">+20%</font>. Galapagos (NASDAQ:<a href='https://seekingalpha.com/symbol/GLPG' title='Galapagos NV'>GLPG</a>) <font color=\"green\">+17%</font>. Soliton (NASDAQ:<a href='https://seekingalpha.com/symbol/SOLY' title='Soliton, Inc.'>SOLY</a>) <font color=\"green\">+12%</font>. Viking Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/VKTX' title='Viking Therapeutics, Inc.'>VKTX</a>) <font color=\"green\">+12%</font>. Tetraphase Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/TTPH' title='Tetraphase Pharmaceuticals, Inc.'>TTPH</a>) <font color=\"green\">+7%</font>.</li><li><b>Losers: </b>ENDRA Life Sciences (NASDAQ:<a href='https://seekingalpha.com/symbol/NDRA' title='ENDRA Life Sciences Inc.'>NDRA</a>) <font color=\"red\">-43%</font>. Vermillion (NASDAQ:<a href='https://seekingalpha.com/symbol/VRML' title='Vermillion, Inc.'>VRML</a>) <font color=\"red\">-16%</font>. Chiasma (NASDAQ:<a href='https://seekingalpha.com/symbol/CHMA' title='Chiasma, Inc.'>CHMA</a>) <font color=\"red\">-15%</font>. Tyme Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/TYME' title='Tyme Technologies, Inc.'>TYME</a>) <font color=\"red\">-14%</font>. Rhythm Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/RYTM' title='Rhythm Pharmaceuticals, Inc.'>RYTM</a>) <font color=\"red\">-8%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3446923\" data-linked=\"Seelos Therapeutics leads healthcare gainers; Vermillion and Chiasma among the losers\" data-tweet=\"$SEEL $GLPG $SOLY - Seelos Therapeutics leads healthcare gainers; Vermillion and Chiasma among the losers https://seekingalpha.com/news/3446923-seelos-therapeutics-leads-healthcare-gainers-vermillion-and-chiasma-among-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3446923-seelos-therapeutics-leads-healthcare-gainers-vermillion-and-chiasma-among-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:03 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3446919\" data-ts=\"1553871271\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WW\" target=\"_blank\">WW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3446919-wwplus-4-after-new-oprah-campaign-launches\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">WW +4% after new Oprah campaign launches</a></h4><ul> <li>WW (WTW) is <font color=\"green\">up 3.64%</font> in a move being attributed to the company's new <a href=\"https://seekingalpha.com/pr/17459595-oprah-winfrey-surprises-ww-members-calls-celebrate-weight-loss-success\" target=\"_blank\">marketing campaign</a> with Oprah Winfrey.</li> <li>The campaign features Winfrey talking one-on-one with WW members about why the weight loss and healthier habits program works.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3446919\" data-linked=\"WW +4% after new Oprah campaign launches\" data-tweet=\"$WW - WW +4% after new Oprah campaign launches https://seekingalpha.com/news/3446919-wwplus-4-after-new-oprah-campaign-launches?source=tweet\" data-url=\"https://seekingalpha.com/news/3446919-wwplus-4-after-new-oprah-campaign-launches\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:54 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>17&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3446917\" data-ts=\"1553870988\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ACH\" target=\"_blank\">ACH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3446917-chalco-passes-rusal-worlds-second-biggest-listed-aluminum-producer\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Chalco passes Rusal as world&#39;s second biggest listed aluminum producer</a></h4><ul><li>Aluminum Corp. of China (<a href='https://seekingalpha.com/symbol/ACH' title='Aluminum Corporation of China Limited'>ACH</a> <font color='red'>-2.1%</font>) says it <a href=\"https://www.reuters.com/article/us-china-aluminium-chalco/chinas-chalco-leapfrogs-rusal-as-second-biggest-listed-aluminum-producer-idUSKCN1RA0CB\" target=\"_blank\">increased annual aluminum production by 16%</a> in 2018, moving it ahead of Russia\u2019s Rusal (<a href='https://seekingalpha.com/symbol/RUALF' title='United Company Rusal PLC'>OTC:RUALF</a>) as the world\u2019s second biggest publicly traded producer of the metal.</li><li>Chalco said in a presentation that its aluminum output totaled 4.17M metric tons last year, beating the 3.75M mt produced by Rusal.</li><li>Chalco managed to raise annual output despite being forced to close some production toward the end of the year as Shanghai aluminum prices fell; it already has shuttered 200K mt of capacity this year, while Rusal will soon launch the second line of its Boguchansk aluminum smelter in Siberia.</li><li>ACH just posted its <a href=\"https://seekingalpha.com/news/3446604-chalco-posts-first-quarterly-loss-since-2015\" target=\"_blank\">first quarterly loss in more than three years</a> and said annual net profits fell last year due to low aluminum prices and slack domestic demand.</li></ul><div class=\"tiny-share-widget\" data-id=\"3446917\" data-linked=\"Chalco passes Rusal as world&#39;s second biggest listed aluminum producer\" data-tweet=\"$ACH $RUALF - Chalco passes Rusal as world&#39;s second biggest listed aluminum producer https://seekingalpha.com/news/3446917-chalco-passes-rusal-worlds-second-biggest-listed-aluminum-producer?source=tweet\" data-url=\"https://seekingalpha.com/news/3446917-chalco-passes-rusal-worlds-second-biggest-listed-aluminum-producer\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:49 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3446913\" data-ts=\"1553870954\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ATBPF\" target=\"_blank\">ATBPF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3446913-antibe-up-5-on-launch-of-mid-stage-study-of-atbminus-346\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Antibe up 5% on launch of mid-stage study of ATB-346</a></h4><ul><li>Thinly traded nano cap Antibe Therapeutics (<a href='https://seekingalpha.com/symbol/ATBPF' title='Antibe Therapeutics Inc.'>OTCQB:ATBPF</a> <font color=\"green\">+4.5%</font>) is up on below-average volume on the heels of the start of <a href=\"https://seekingalpha.com/pr/17459522-antibe-therapeutics-announces-commencement-phase-2b-dose-ranging-efficacy-study-lead-drug\" target=\"_blank\">enrollment </a>in a 360-subject Phase 2b dose-ranging study evaluating lead candidate ATB-346 for reducing pain in patients with knee osteoarthritis. Topline data should be available this summer.</li><li>If all goes well, Phase 3 trials will follow.</li><li><a href=\"http://www.antibethera.com/pipeline/atb-346/\" target=\"_blank\">ATB-346</a> is a derivative of naproxen, the most commonly prescribed NSAID (non-steroidal anti-inflammatory drug). Its value proposition is naproxen-equivalent anti-inflammatory action without the gastrointestinal ulceration.</li></ul><div class=\"tiny-share-widget\" data-id=\"3446913\" data-linked=\"Antibe up 5% on launch of mid-stage study of ATB-346\" data-tweet=\"$ATBPF - Antibe up 5% on launch of mid-stage study of ATB-346 https://seekingalpha.com/news/3446913-antibe-up-5-on-launch-of-mid-stage-study-of-atbminus-346?source=tweet\" data-url=\"https://seekingalpha.com/news/3446913-antibe-up-5-on-launch-of-mid-stage-study-of-atbminus-346\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:49 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3446914\" data-ts=\"1553870780\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MU\" target=\"_blank\">MU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3446914-micronplus-4_5-on-potential-samsung-dram-issues\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Micron +4.5% on potential Samsung DRAM issues</a></h4><ul><li>CLSA notes that some Korean media outlets are reporting that Amazon's DRAM chips from Samsung (<a href='https://seekingalpha.com/symbol/SSNNF' title='Samsung Electronics Co., Ltd.'>OTC:SSNNF</a>,<a href='https://seekingalpha.com/symbol/SSNLF' title='Samsung Electronics Co., Ltd.'>OTC:SSNLF</a>) might have quality issues.</li><li>Amazon is reportedly in talks with competitors including Micron (NASDAQ:<a href='https://seekingalpha.com/symbol/MU' title='Micron Technology, Inc.'>MU</a>) and SK Hynix (<a href='https://seekingalpha.com/symbol/HXSCF' title='SK Hynix, Inc.'>OTC:HXSCF</a>,<a href='https://seekingalpha.com/symbol/HXSCL' title='SK Hynix, Inc.'>OTC:HXSCL</a>) about potential replacements if a Samsung settlement isn't reached.</li><li>CLSA analyst Sanjeev Rana says the problem could have serious implications for Samsung if it's not resolved, including customer refunds, DRAM inventory replacement at discount, market share loss, and litigation.</li><li>Micron shares are <font color=\"green\">up 4.5%</font> to $41.12. DRAM peer Intel (NASDAQ:<a href='https://seekingalpha.com/symbol/INTC' title='Intel Corporation'>INTC</a>) <font color=\"green\">gains 1.2%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3446914\" data-linked=\"Micron +4.5% on potential Samsung DRAM issues\" data-tweet=\"$MU $SSNNF $SSNLF - Micron +4.5% on potential Samsung DRAM issues https://seekingalpha.com/news/3446914-micronplus-4_5-on-potential-samsung-dram-issues?source=tweet\" data-url=\"https://seekingalpha.com/news/3446914-micronplus-4_5-on-potential-samsung-dram-issues\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:46 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>95&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3446912\" data-ts=\"1553870570\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OXM\" target=\"_blank\">OXM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3446912-oxford-industries-down-3-post-q4-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Oxford Industries down 3% post Q4 results</a></h4><ul><li>Oxford Industries (<a href='https://seekingalpha.com/symbol/OXM' title='Oxford Industries, Inc.'>OXM</a> <font color=\"red\">-3.2%</font>) reports Q4 sales growth of 2% Y/Y to $298.5M, and 2% increase in comparable store sales.</li><li>Tommy Bahama sales of $192.4M (-4.8% Y/Y); gross margin of 61.1% <font color=\"green\">up by 140 bps</font>; and operating margin of 12.1% <font color=\"green\">up by 80 bps</font>.</li><li>Lilly Pulitzer sales of $63.8M (+12.2% Y/Y); gross margin 51.1% <font color=\"red\">down by 820 bps</font>; and operating margin of 5.4%<font color=\"green\"> up by 10 bps</font>.</li><li>Southern Tide sales of $10.5M (+8.4% Y/Y); gross margin of 50.1%<font color=\"green\"> up by 500 bps</font>; and operating margin of 12% <font color=\"green\">up by 440 bps</font>.</li><li>Q4 Overall gross margin <font color=\"red\">declined 21 bps</font> to 55.1%; and Adj. gross margin <font color=\"red\">declined by 140 bps</font> to 55.3%.</li><li>Operating margin <font color=\"green\">improved by 106 bps</font> to 7.4%; and Adj. operating slightly <font color=\"green\">improved by 6 bps</font> to 8.1%.</li><li>SG&amp;A expenses were $145.8M (-1% Y/Y); and as percentage of sales declined by 140 bps to 48.8%.</li><li>Cash provided by operating activities YTD was $96.38M, compared to $118.59M a year ago. Free cash flow $59.3M, compared to $79.8M a year ago.</li><li><strong>1Q19 Guidance:</strong> GAAP EPS $1.14 to $1.24; and Adj. EPS $1.15 to $1.25.</li><li><strong>FY19 Guidance:</strong> $4.42 to $4.62; and Adj. EPS $4.45 - $4.65.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3446644-oxford-industries-beats-0_03-misses-revenue\" target=\"_blank\">Oxford Industries beats by $0.03, misses on revenue</a> (March 28)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3446676-oxford-industries-declares-0_37-dividend\" target=\"_blank\">Oxford Industries declares $0.37 dividend</a> (March 28)</li></ul><div class=\"tiny-share-widget\" data-id=\"3446912\" data-linked=\"Oxford Industries down 3% post Q4 results\" data-tweet=\"$OXM - Oxford Industries down 3% post Q4 results https://seekingalpha.com/news/3446912-oxford-industries-down-3-post-q4-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3446912-oxford-industries-down-3-post-q4-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:42 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3446905\" data-ts=\"1553869849\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NDRA\" target=\"_blank\">NDRA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3446905-endra-down-43-on-taeus-data\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Endra down 43% on TAEUS data</a></h4><ul><li>Thinly traded nano cap ENDRA Life Sciences (<a href='https://seekingalpha.com/symbol/NDRA' title='ENDRA Life Sciences Inc.'>NDRA</a> <font color=\"red\">-43.3%</font>) slumps on more than double normal volume following the release of results from the first human study assessing the feasibility of its Thermo Acoustic Enhanced Ultrasound &#40;TAEUS&#41; in measuring liver fat, data investors appear to be disappointed with.</li><li>21 subjects with less than 6% liver fat fraction by MRI (considered normal) and four subjects with 8.0 - 22.4% fat fraction (considered mild nonalcoholic fatty liver disease or NAFLD) were measured.</li><li>The correlation between TAEUS and fat fraction by MRI showed an R-squared value of 0.61 (0.0 means that the statistical model explains none of the data variability while 1.0 means that model explains all of the variability). Ideally, the correlation would be close to 1.0 here.</li><li>By comparison, the R-squared value between Body Mass Index &#40;BMI&#41; and fat fraction by MRI was 0.19 and 0.31 between abdominal fat thickness (determined by ultrasound) and MRI fat fraction.</li><li>The next phase of the study will add people with mild, moderate and severe fatty liver disease (6 - 50% liver fat fraction by MRI). The company says these data may \"vary significantly\" from the results observed thus far.</li><li>ENDRA says TAEUS uses radio frequency &#40;RF&#41; to enhance ultrasound, potentially representing a much lower cost option for liver fat measurement compared to MRI.</li></ul><div class=\"tiny-share-widget\" data-id=\"3446905\" data-linked=\"Endra down 43% on TAEUS data\" data-tweet=\"$NDRA - Endra down 43% on TAEUS data https://seekingalpha.com/news/3446905-endra-down-43-on-taeus-data?source=tweet\" data-url=\"https://seekingalpha.com/news/3446905-endra-down-43-on-taeus-data\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:30 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3446909\" data-ts=\"1553869671\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FFIV\" target=\"_blank\">FFIV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3446909-f5-networksplus-2_1-piper-sees-negative-risks-off\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">F5 Networks +2.1% as Piper sees negative risks off</a></h4><ul>   <li>F5 Networks (NASDAQ:<a href='https://seekingalpha.com/symbol/FFIV' title='F5 Networks, Inc.'>FFIV</a>) is <font color=\"green\">up 2.1%</font> after a boost to Neutral from Underweight at Piper Jaffray.</li>    <li>Downside catalysts have played out for the most part, writes analyst James Fish, and <a href=\"https://seekingalpha.com/news/3441642-f5-acquire-nginx-670m-enterprise-value\" target=\"_blank\">acquiring Nginx</a> is the \"right strategic move.\" The stock's not without long-term concerns, however, including software transition and competition.</li>    <li>He's raised his price target to $163 from $157, now implying 3.8% upside.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3446909\" data-linked=\"F5 Networks +2.1% as Piper sees negative risks off\" data-tweet=\"$FFIV - F5 Networks +2.1% as Piper sees negative risks off https://seekingalpha.com/news/3446909-f5-networksplus-2_1-piper-sees-negative-risks-off?source=tweet\" data-url=\"https://seekingalpha.com/news/3446909-f5-networksplus-2_1-piper-sees-negative-risks-off\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:27 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3446904\" data-ts=\"1553868767\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3446904-auto-dealer-stocks-ride-higher-carmax\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Auto dealer stocks ride higher with CarMax</a></h4><ul> <li>Strong results from CarMax have given a lift to the auto dealer sector.</li> <li>CarMax recorded double-digit pretax earnings growth during the quarter and same-store sales volume growth of 3.0%.</li> <li>Gainers include AutoNation (<a href='https://seekingalpha.com/symbol/AN' title='AutoNation, Inc.'>AN</a> <font color='green'>+2.6%</font>), Group 1 Automotive (<a href='https://seekingalpha.com/symbol/GPI' title='Group 1 Automotive, Inc.'>GPI</a> <font color='green'>+1.5%</font>), Lithia Motors (<a href='https://seekingalpha.com/symbol/LAD' title='Lithia Motors, Inc.'>LAD</a> <font color='green'>+2%</font>), Asbury Automotive Group (<a href='https://seekingalpha.com/symbol/ABG' title='Asbury Automotive Group, Inc.'>ABG</a> <font color='green'>+1.2%</font>), Sonic Automotive (<a href='https://seekingalpha.com/symbol/SAH' title='Sonic Automotive, Inc.'>SAH</a> <font color='green'>+2.9%</font>), CarGurus (<a href='https://seekingalpha.com/symbol/CARG' title='CarGurus, Inc.'>CARG</a> <font color='green'>+1.6%</font>) and Penske Automotive Group (<a href='https://seekingalpha.com/symbol/PAG' title='Penske Automotive Group, Inc.'>PAG</a> <font color='green'>+1.3%</font>).</li><li>Previously: <a href=\"https://seekingalpha.com/news/3446805-carmax-plus-4-percent-comfortable-profit-beat\" target=\"_blank\">CarMax +4% after comfortable profit beat</a> (March 29)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3446904\" data-linked=\"Auto dealer stocks ride higher with CarMax\" data-tweet=\"$AN $GPI $LAD - Auto dealer stocks ride higher with CarMax https://seekingalpha.com/news/3446904-auto-dealer-stocks-ride-higher-carmax?source=tweet\" data-url=\"https://seekingalpha.com/news/3446904-auto-dealer-stocks-ride-higher-carmax\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:12 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3446900\" data-ts=\"1553868352\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3446900-chinese-airline-stocks-gain-altitude\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Chinese airline stocks gain altitude</a></h4><ul> <li>Positive steps in U.S.-China trade negotiations have Chinese airline stocks on the move again.</li> <li>China Eastern Airlines (NYSE:<a href='https://seekingalpha.com/symbol/CEA' title='China Eastern Airlines Corporation Limited'>CEA</a>) is <font color=\"green\">up 3.95%</font>, while China Southern Airlines (NYSE:<a href='https://seekingalpha.com/symbol/ZNH' title='China Southern Airlines Company Limited'>ZNH</a>) is showing a <font color=\"green\">3.88% gain</font>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3446900\" data-linked=\"Chinese airline stocks gain altitude\" data-tweet=\"$CEA $ZNH - Chinese airline stocks gain altitude https://seekingalpha.com/news/3446900-chinese-airline-stocks-gain-altitude?source=tweet\" data-url=\"https://seekingalpha.com/news/3446900-chinese-airline-stocks-gain-altitude\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:05 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3446893\" data-ts=\"1553867857\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SELB\" target=\"_blank\">SELB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3446893-selecta-bio-launches-study-comparing-selminus-212-to-horizons-krystexxa-shares-up-3\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Selecta Bio launches study comparing SEL-212 to Horizon&#39;s Krystexxa; shares up 3%</a></h4><ul><li>Selecta Biosciences (<a href='https://seekingalpha.com/symbol/SELB' title='Selecta Biosciences, Inc.'>SELB</a> <font color=\"green\">+2.8%</font>) <a href=\"https://seekingalpha.com/pr/17459592-selecta-biosciences-initiates-head-head-clinical-trial-compare-selminus-212-vs-krystexxa\" target=\"_blank\">initiates </a>a six-month head-to-head clinical trial, COMPARE, evaluating lead drug SEL-212 versus Horizon Pharma's (<a href='https://seekingalpha.com/symbol/HZNP' title='Horizon Pharma plc'>HZNP</a> <font color=\"red\">-0.2%</font>) <a href=\"https://www.krystexxa.com/\" target=\"_blank\">Krystexxa </a>(pegloticase) in adults with chronic refractory gout.</li><li>Enrollment will be 100 - 150 subjects. The primary endpoint is the maintenance of serum uric acid levels less than 6.0 mg/dL at month 6 (normal range is 2.4 - 6.0 mg/dL in women and 2.4 - 7.0 mg/dL in men according to Chemocare).</li><li>Preliminary data should be available in Q4.</li><li>The company plans to launch a Phase 3 study in Q4 as well.</li><li>SEL-212 is a combination of a uricase enzyme called pegadricase and RVP-Rapamycin (to prevent the formation of anti-drug antibodies) administered once per month. Pegloticase is a uricase enzyme administered every two weeks.</li></ul><div class=\"tiny-share-widget\" data-id=\"3446893\" data-linked=\"Selecta Bio launches study comparing SEL-212 to Horizon&#39;s Krystexxa; shares up 3%\" data-tweet=\"$SELB $HZNP - Selecta Bio launches study comparing SEL-212 to Horizon&#39;s Krystexxa; shares up 3% https://seekingalpha.com/news/3446893-selecta-bio-launches-study-comparing-selminus-212-to-horizons-krystexxa-shares-up-3?source=tweet\" data-url=\"https://seekingalpha.com/news/3446893-selecta-bio-launches-study-comparing-selminus-212-to-horizons-krystexxa-shares-up-3\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:57 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3446881\" data-ts=\"1553866677\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MCD\" target=\"_blank\">MCD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3446881-oppenheimer-adjusts-estimates-on-mcdonalds\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Oppenheimer adjusts estimates on McDonald&#39;s</a></h4><ul> <li>Oppenheimer checks in on McDonald's (<a href='https://seekingalpha.com/symbol/MCD' title='McDonald&#39;s Corporation'>MCD</a> <font color=\"green\">+0.2%</font>) about a month before the restaurant company is due to release earnings (4/30). The firm adjusts its estimates to the new operating segment alignment at McDonald's and margin pressures.</li> <li>\"We expect a healthy quarter with US-SSS of +2.7% (vs Street's +2.9%) and EPS of $1.69 (below Street's $1.78),\" notes analyst Brian Bittner.</li> <li>Looking ahead, Oppenheimer sees flat to low single-digit EPS growth for the full year and mid to high single-digit EPS growth in 2020. High-single digit growth is forecast for 2021.</li><li>McDonald's is rated at Perform by Oppenheimer.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3446881\" data-linked=\"Oppenheimer adjusts estimates on McDonald&#39;s\" data-tweet=\"$MCD - Oppenheimer adjusts estimates on McDonald&#39;s https://seekingalpha.com/news/3446881-oppenheimer-adjusts-estimates-on-mcdonalds?source=tweet\" data-url=\"https://seekingalpha.com/news/3446881-oppenheimer-adjusts-estimates-on-mcdonalds\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:37 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3446880\" data-ts=\"1553866667\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CHMA\" target=\"_blank\">CHMA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3446880-chiasma-prices-stock-offering-4_75-shares-down-20\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Chiasma prices stock offering at $4.75; shares down 20%</a></h4><ul><li>Thinly traded micro cap Chiasma (<a href='https://seekingalpha.com/symbol/CHMA' title='Chiasma, Inc.'>CHMA</a> <font color=\"red\">-20.1%</font>) is down on double normal volume out of the gate this morning after <a href=\"https://seekingalpha.com/pr/17459830-chiasma-announces-pricing-underwritten-public-offering-30_0-million-common-stock\" target=\"_blank\">pricing</a> its public offering of ~6.3M common shares at $4.75 per share. Underwriters over-allotment is an additional ~947K shares. Closing date is April 2.</li><li>Yesterday's close was $5.76.</li></ul><div class=\"tiny-share-widget\" data-id=\"3446880\" data-linked=\"Chiasma prices stock offering at $4.75; shares down 20%\" data-tweet=\"$CHMA - Chiasma prices stock offering at $4.75; shares down 20% https://seekingalpha.com/news/3446880-chiasma-prices-stock-offering-4_75-shares-down-20?source=tweet\" data-url=\"https://seekingalpha.com/news/3446880-chiasma-prices-stock-offering-4_75-shares-down-20\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:37 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3446869\" data-ts=\"1553866110\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMRS\" target=\"_blank\">AMRS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3446869-amyrisplus-21-on-earning-first-milestone-payment-of-10m\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Amyris +21% on earning first milestone payment of $10M</a></h4><ul> <li>Amyris (NASDAQ:<a href='https://seekingalpha.com/symbol/AMRS' title='Amyris, Inc.'>AMRS</a>) has <a href=\"https://seekingalpha.com/pr/17459712-amyris-delivers-first-cbd-milestone-earns-10-million\" target=\"_blank\">successfully</a> delivered on its first milestone for its cannabinoid partner, LAVVAN, earning its first payment of $10M, which is part of a $300M collaboration before future royalty payments.</li>   <li>Amyris uses yeast to create pure, sustainable, fermented natural products.</li><li>Shares are up <font color=\"green\">21%</font> premarket.</li>    </ul><div class=\"tiny-share-widget\" data-id=\"3446869\" data-linked=\"Amyris +21% on earning first milestone payment of $10M\" data-tweet=\"$AMRS - Amyris +21% on earning first milestone payment of $10M https://seekingalpha.com/news/3446869-amyrisplus-21-on-earning-first-milestone-payment-of-10m?source=tweet\" data-url=\"https://seekingalpha.com/news/3446869-amyrisplus-21-on-earning-first-milestone-payment-of-10m\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:28 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3446865\" data-ts=\"1553865830\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TYME\" target=\"_blank\">TYME</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3446865-tyme-tech-down-20-on-pricing-registered-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tyme Tech down 20% on pricing registered offering</a></h4><ul> <li>Tyme Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/TYME' title='Tyme Technologies, Inc.'>TYME</a>) has <a href=\"https://seekingalpha.com/pr/17459643-tyme-technologies-announces-pricing-12-million-registered-offering\" target=\"_blank\">priced</a> a registered offering of 8M shares of common stock and warrants to purchase 8M common stock at a combined purchase price of $1.50/ share of common stock and warrant, resulting in gross proceeds of ~$12M.</li>   <li>Net proceeds will be used to continue the development of its clinical and preclinical assets as well as for general corporate purposes.</li><li>Closing date is April 2.</li><li>Shares are down <font color=\"red\">20%</font> premarket.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3446865\" data-linked=\"Tyme Tech down 20% on pricing registered offering\" data-tweet=\"$TYME - Tyme Tech down 20% on pricing registered offering https://seekingalpha.com/news/3446865-tyme-tech-down-20-on-pricing-registered-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3446865-tyme-tech-down-20-on-pricing-registered-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:23 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3446859\" data-ts=\"1553865608\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CELG\" target=\"_blank\">CELG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3446859-celgene-up-6-premarket-on-iss-backing-of-merger\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Celgene up 6% premarket on ISS backing of merger</a></h4><ul><li>Celgene (NASDAQ:<a href='https://seekingalpha.com/symbol/CELG' title='Celgene Corporation'>CELG</a>) is up <font color=\"green\">6%</font> premarket on light volume in response to proxy advisor ISS supporting its announced merger with Bristol-Myers Squibb (NYSE:<a href='https://seekingalpha.com/symbol/BMY' title='Bristol-Myers Squibb Company'>BMY</a>) (<font color=\"red\">-1%</font> premarket).</li><li>Shareholders at both companies will vote on the tie-up on April 12.</li></ul><div class=\"tiny-share-widget\" data-id=\"3446859\" data-linked=\"Celgene up 6% premarket on ISS backing of merger\" data-tweet=\"$CELG $BMY - Celgene up 6% premarket on ISS backing of merger https://seekingalpha.com/news/3446859-celgene-up-6-premarket-on-iss-backing-of-merger?source=tweet\" data-url=\"https://seekingalpha.com/news/3446859-celgene-up-6-premarket-on-iss-backing-of-merger\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:20 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>16&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3446858\" data-ts=\"1553865530\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3446858-bb-vjet-and-kmx-among-premarket-gainers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BB, VJET and KMX among premarket gainers</a></h4><ul><li>Seelos Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/SEEL' title='Seelos Therapeutics, Inc.'>SEEL</a>) <font color=\"green\">+32%</font> on <a href=\"https://seekingalpha.com/news/3446683-seelos-therapeutics-reports-fy-results\" target=\"_blank\">FY results</a> and <a href=\"https://seekingalpha.com/news/3446848-seelos-therapeutics-provides-corporate-highlights-pipeline-developments-shares-33-percent\" target=\"_blank\">pipeline developments</a>.</li><li>Urban Tea (NASDAQ:<a href='https://seekingalpha.com/symbol/MYT' title='Urban Tea, Inc.'>MYT</a>) <font color=\"green\">+25%</font>.</li><li>Progress Software (NASDAQ:<a href='https://seekingalpha.com/symbol/PRGS' title='Progress Software Corporation'>PRGS</a>) <font color=\"green\">+25%</font> on <a href=\"https://seekingalpha.com/news/3446669-progress-software-beats-0_03-beats-revenue\" target=\"_blank\">Q1 earnings</a>.</li><li>Amyris (NASDAQ:<a href='https://seekingalpha.com/symbol/AMRS' title='Amyris, Inc.'>AMRS</a>) <font color=\"green\">+25%</font> on <a href=\"https://seekingalpha.com/pr/17459712-amyris-delivers-first-cbd-milestone-earns-10-million\" target=\"_blank\">earning</a> its first payment of $10 million, which is part of a $300 million collaboration before future royalty payments.</li><li>Marker Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/MRKR' title='Marker Therapeutics, Inc.'>MRKR</a>) <font color=\"green\">+21%</font> on business and clinical <a href=\"https://seekingalpha.com/news/3446851-marker-therapeutics-provides-business-clinical-update\" target=\"_blank\">update</a>.</li><li>Galapagos NV (NASDAQ:<a href='https://seekingalpha.com/symbol/GLPG' title='Galapagos NV'>GLPG</a>) <font color=\"green\">+15%</font> on positive filgotinib <a href=\"https://seekingalpha.com/news/3446782-gilead-galapagos-premarket-positive-filgotinib-data\" target=\"_blank\">data</a>.</li><li>voxeljet AG (NYSE:<a href='https://seekingalpha.com/symbol/VJET' title='voxeljet AG'>VJET</a>) <font color=\"green\">+14%</font> on <a href=\"https://seekingalpha.com/news/3446714-voxeljet-ag-reports-q4-results\" target=\"_blank\">Q4 earnings</a>.</li><li>BlackBerry (NYSE:<a href='https://seekingalpha.com/symbol/BB' title='BlackBerry Limited'>BB</a>) <font color=\"green\">+11%</font> on <a href=\"https://seekingalpha.com/news/3446771-blackberry-beats-0_05-beats-revenue\" target=\"_blank\">Q4 earnings</a>.</li><li>China Advanced Construction Materials (NASDAQ:<a href='https://seekingalpha.com/symbol/CADC' title='China Advanced Construction Materials Group, Inc.'>CADC</a>) <font color=\"green\">+11%</font>.</li><li>ZK International Group (NASDAQ:<a href='https://seekingalpha.com/symbol/ZKIN' title='ZK International Group Co., Ltd.'>ZKIN</a>) <font color=\"green\">+9%</font>.</li><li>CarMax (NYSE:<a href='https://seekingalpha.com/symbol/KMX' title='CarMax, Inc.'>KMX</a>) <font color=\"green\">+5%</font> on <a href=\"https://seekingalpha.com/news/3446795-carmax-beats-0_10-misses-revenue\" target=\"_blank\">Q4 earnings</a>.</li><li>Viking Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/VKTX' title='Viking Therapeutics, Inc.'>VKTX</a>) <font color=\"green\">+5%</font> on positive analyst <a href=\"https://seekingalpha.com/news/3446852-viking-therapeutics-6-percent-premarket-leerink-bullish\" target=\"_blank\">upgrade</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3446858\" data-linked=\"BB, VJET and KMX among premarket gainers\" data-tweet=\"$SEEL $MYT $PRGS - BB, VJET and KMX among premarket gainers https://seekingalpha.com/news/3446858-bb-vjet-and-kmx-among-premarket-gainers?source=tweet\" data-url=\"https://seekingalpha.com/news/3446858-bb-vjet-and-kmx-among-premarket-gainers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:18 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3446857\" data-ts=\"1553865521\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3446857-azn-and-sgh-among-premarket-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AZN and SGH among premarket losers</a></h4><ul><li>ENDRA Life Sciences (NASDAQ:<a href='https://seekingalpha.com/symbol/NDRA' title='ENDRA Life Sciences Inc.'>NDRA</a>) <font color=\"red\">-28%</font> on <a href=\"https://seekingalpha.com/pr/17459724-endra-life-sciences-reports-initial-findings-first-human-taeus-feasibility-study-liver-fat\" target=\"_blank\">reporting</a> initial findings on first human TAEUS feasibility study of liver fat.</li><li>Chiasma (NASDAQ:<a href='https://seekingalpha.com/symbol/CHMA' title='Chiasma, Inc.'>CHMA</a>) <font color=\"red\">-19%</font> on <a href=\"https://seekingalpha.com/news/3446636-chiasma-readies-equity-offering-shares-13-percent-hours\" target=\"_blank\">launching</a> equity offering.</li><li>SMART Global Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/SGH' title='SMART Global Holdings, Inc.'>SGH</a>) <font color=\"red\">-20%</font> on <a href=\"https://seekingalpha.com/news/3446633-smart-global-beats-0_02-misses-revenue\" target=\"_blank\">Q2 result</a>.</li><li>Euro Tech Holdings Company (NASDAQ:<a href='https://seekingalpha.com/symbol/CLWT' title='Euro Tech Holdings Company Limited'>CLWT</a>) <font color=\"red\">-17%</font>.</li><li>Tyme Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/TYME' title='Tyme Technologies, Inc.'>TYME</a>) <font color=\"red\">-16%</font> on <a href=\"https://seekingalpha.com/pr/17459643-tyme-technologies-announces-pricing-12-million-registered-offering\" target=\"_blank\">pricing</a> $12M registered offering.</li><li>Safe-T Group (NASDAQ:<a href='https://seekingalpha.com/symbol/SFET' title='Safe-T Group Ltd'>SFET</a>) <font color=\"red\">-14%</font>.</li><li>SenesTech (NASDAQ:<a href='https://seekingalpha.com/symbol/SNES' title='SenesTech, Inc.'>SNES</a>) <font color=\"red\">-14%</font> on <a href=\"https://seekingalpha.com/news/3446640-senestech-reports-fy-results\" target=\"_blank\">FY results</a>.</li><li>RH (NYSE:<a href='https://seekingalpha.com/symbol/RH' title='RH'>RH</a>) <font color=\"red\">-14%</font> on <a href=\"https://seekingalpha.com/news/3446665-rh-beats-0_14-misses-revenue\" target=\"_blank\">Q4 earnings</a>.</li><li>Planet Green Holdings (NYSEMKT:<a href='https://seekingalpha.com/symbol/PLAG' title='Planet Green Holdings Corp.'>PLAG</a>) <font color=\"red\">-9%</font>.</li><li>China Internet Nationwide Financial Services (NASDAQ:<a href='https://seekingalpha.com/symbol/CIFS' title='China Internet Nationwide Financial Services Inc.'>CIFS</a>) <font color=\"red\">-8%</font>.</li><li>Tenax Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/TENX' title='Tenax Therapeutics, Inc.'>TENX</a>) <font color=\"red\">-8%</font>.</li><li>AstraZeneca (NYSE:<a href='https://seekingalpha.com/symbol/AZN' title='AstraZeneca PLC'>AZN</a>) <font color=\"red\">-6%</font> on $3.5B <a href=\"https://seekingalpha.com/news/3446796-astrazeneca-6-percent-3_5b-capital-raise\" target=\"_blank\">capital raise</a>.</li><li>Reebonz Holding (NASDAQ:<a href='https://seekingalpha.com/symbol/RBZ' title='Reebonz Holding Limited'>RBZ</a>) <font color=\"red\">-1%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3446857\" data-linked=\"AZN and SGH among premarket losers\" data-tweet=\"$NDRA $CHMA $SGH - AZN and SGH among premarket losers https://seekingalpha.com/news/3446857-azn-and-sgh-among-premarket-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3446857-azn-and-sgh-among-premarket-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:18 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3446856\" data-ts=\"1553865502\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XLNX\" target=\"_blank\">XLNX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3446856-xilinxplus-1_8-mizuho-praises-5g-leadership\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Xilinx +1.8% as Mizuho praises 5G leadership</a></h4><ul>   <li>Xilinx (NASDAQ:<a href='https://seekingalpha.com/symbol/XLNX' title='Xilinx, Inc.'>XLNX</a>) is <font color=\"green\">up 1.8%</font> premarket with Mizuho boosting estimates and its price target on 5G momentum.</li>    <li>The company's a \"significant\" leader in 5G and could see orders up 50% or more this year as it dominates the rollout in Asia, the firm says.</li>    <li>It's raised its price target to $140 from $107, implying 10.6% upside.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3446856\" data-linked=\"Xilinx +1.8% as Mizuho praises 5G leadership\" data-tweet=\"$XLNX - Xilinx +1.8% as Mizuho praises 5G leadership https://seekingalpha.com/news/3446856-xilinxplus-1_8-mizuho-praises-5g-leadership?source=tweet\" data-url=\"https://seekingalpha.com/news/3446856-xilinxplus-1_8-mizuho-praises-5g-leadership\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:18 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3446855\" data-ts=\"1553865216\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/USO\" target=\"_blank\">USO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3446855-crude-prices-resume-upward-march-toward-best-quarter-in-decade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Crude prices resume upward march toward best quarter in a decade</a></h4><ul><li>Crude oil prices resume their climb, putting U.S. West Texas Intermediate on track to gain ~33% for Q1 in its <a href=\"https://www.cnbc.com/2019/03/29/oil-market-opec-supply-cuts-us-sanctions-in-focus.html\" target=\"_blank\">biggest quarterly rise since 2009</a>; WTI <font color=\"green\">+2.1%</font> to $60.56/bbl, Brent <font color=\"green\">+1.5%</font> to $$68.82/bbl.</li><li>\"Production cuts from the OPEC+ group of producers have been the main  reason for the dramatic recovery since the 38% price slump seen  during the final quarter of last year,\" said Ole Hansen, head of  commodity strategy at Saxo Bank.</li><li>Barclays says oil prices \"are likely to move still higher  in Q2 and average $73 per barrel ($65 WTI), and $70 for the year.\"</li><li>Despite the surging prices, analysts are concerned about  future oil demand in the face of signs that the global economy may move into a  recession.</li><li>\"Business confidence has weakened in recent months [and] global  manufacturing PMIs are about to move into contraction,\" says BofA Merrill Lynch, but given OPEC production cuts, oil  prices likely will rise in the short-term, with Brent prices forecast to average  $74/bbl in Q2.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/USO' title='The United States Oil ETF, LP'>USO</a>, <a href='https://seekingalpha.com/symbol/XLE' title='Energy Select Sector SPDR ETF'>XLE</a>, <a href='https://seekingalpha.com/symbol/OIL' title='iPath S&P Crude Oil Total Return Index ETN'>OIL</a>, <a href='https://seekingalpha.com/symbol/UWT' title='VelocityShares 3X Long Crude ETN'>UWT</a>, <a href='https://seekingalpha.com/symbol/UCO' title='ProShares Ultra Bloomberg Crude Oil ETF'>UCO</a>, <a href='https://seekingalpha.com/symbol/DWT' title='VelocityShares 3x Inverse Crude Oil ETN'>DWT</a>, <a href='https://seekingalpha.com/symbol/SCO' title='ProShares UltraShort Bloomberg Crude Oil ETF'>SCO</a>, <a href='https://seekingalpha.com/symbol/BNO' title='The United States Brent Oil ETF, LP'>BNO</a>, <a href='https://seekingalpha.com/symbol/DBO' title='Invesco DB Oil ETF'>DBO</a>, <a href='https://seekingalpha.com/symbol/DTO' title='DB Crude Oil Double Short ETN'>DTO</a>, <a href='https://seekingalpha.com/symbol/USL' title='The United States 12 Month Oil ETF, LP'>USL</a>, <a href='https://seekingalpha.com/symbol/OLO' title='DB Crude Oil Long ETN'>OLO</a>, <a href='https://seekingalpha.com/symbol/SZO' title='DB Crude Oil Short ETN'>SZO</a>, <a href='https://seekingalpha.com/symbol/OLEM' title='iPath Pure Beta Crude Oil ETN'>OLEM</a>, <a href='https://seekingalpha.com/symbol/WTIU' title='ProShares Daily 3x Long Crude ETN'>WTIU</a>, <a href='https://seekingalpha.com/symbol/OILK' title='ProShares K-1 Free Crude Oil Strategy ETF'>OILK</a>, <a href='https://seekingalpha.com/symbol/OILX' title='Etracs S&P GSCI Crude Oil Total Return Index ETN'>OILX</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3446855\" data-linked=\"Crude prices resume upward march toward best quarter in a decade\" data-tweet=\"$USO $XLE $OIL - Crude prices resume upward march toward best quarter in a decade https://seekingalpha.com/news/3446855-crude-prices-resume-upward-march-toward-best-quarter-in-decade?source=tweet\" data-url=\"https://seekingalpha.com/news/3446855-crude-prices-resume-upward-march-toward-best-quarter-in-decade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:13 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>17&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3446852\" data-ts=\"1553864942\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VKTX\" target=\"_blank\">VKTX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3446852-viking-therapeutics-up-6-premarket-leerink-bullish\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Viking Therapeutics up 6% premarket; Leerink bullish</a></h4><ul><li>Viking Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/VKTX' title='Viking Therapeutics, Inc.'>VKTX</a>) is up <font color=\"green\">6%</font> premarket on average volume on the heels of an upgrade to Outperform with a $21 (147% upside) price target at Leerink.</li><li>Data supporting the <a href=\"https://seekingalpha.com/news/3445985-viking-therapeutics-7-percent-premarket-positive-vk2809-data\" target=\"_blank\">efficacy </a>of low-dose VK2809 in NASH will be presented at EASL on April 11.</li></ul><div class=\"tiny-share-widget\" data-id=\"3446852\" data-linked=\"Viking Therapeutics up 6% premarket; Leerink bullish\" data-tweet=\"$VKTX - Viking Therapeutics up 6% premarket; Leerink bullish https://seekingalpha.com/news/3446852-viking-therapeutics-up-6-premarket-leerink-bullish?source=tweet\" data-url=\"https://seekingalpha.com/news/3446852-viking-therapeutics-up-6-premarket-leerink-bullish\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:09 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3446851\" data-ts=\"1553864914\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MRKR\" target=\"_blank\">MRKR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3446851-marker-up-19-premarket-on-pipeline-advancement\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Marker up 19% premarket on pipeline advancement</a></h4><ul><li>Marker Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/MRKR' title='Marker Therapeutics, Inc.'>MRKR</a>) <a href=\"https://seekingalpha.com/pr/17459090-marker-therapeutics-provides-business-clinical-update\" target=\"_blank\">provides</a> a business and clinical update, as well as an overview of upcoming milestones for 2019.</li><li>Marker plans IND submission for Company-sponsored Phase 2 AML study in Q3, with first patient enrolled by the end of 2019.</li><li>The Company is planning two Phase 2 Company-sponsored studies ongoing for TPIV200 in triple-negative breast cancer and ovarian cancer, with interim data anticipated in Q4.</li><li>First update in the solid tumor program is planned for Q2.</li><li>Shares are up <font color=\"green\">19%</font> premarket.</li></ul><div class=\"tiny-share-widget\" data-id=\"3446851\" data-linked=\"Marker up 19% premarket on pipeline advancement\" data-tweet=\"$MRKR - Marker up 19% premarket on pipeline advancement https://seekingalpha.com/news/3446851-marker-up-19-premarket-on-pipeline-advancement?source=tweet\" data-url=\"https://seekingalpha.com/news/3446851-marker-up-19-premarket-on-pipeline-advancement\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:08 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3446848\" data-ts=\"1553864534\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SEEL\" target=\"_blank\">SEEL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3446848-seelos-up-33-premarket-on-pipeline-advancement\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Seelos up 33% premarket on pipeline advancement</a></h4><ul> <li>Seelos Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/SEEL' title='Seelos Therapeutics, Inc.'>SEEL</a>) <a href=\"https://seekingalpha.com/pr/17459240-seelos-therapeutics-provides-update-pipeline-developments-corporate-highlights\" target=\"_blank\">provides</a> an update on recent pipeline developments and corporate highlights.</li><li><strong>Corporate Highlights</strong></li>        <li>The Company successfully transitioned into a publicly traded company on Nasdaq by completing its reverse merger with Apricus BioSciences on January 24.</li><li>Also, Seelos has acquired two exciting new programs: SLS-005, focused on orphan diseases in the CNS, and SLS-007, a family of peptidic inhibitors directed toward alpha-synuclein aggregates in Parkinson\u2019s disease &#40;PD&#41;.</li><li><strong>Update on Pipeline Development</strong></li><li>SLS-002 (intranasal racemic ketamine): The Company plans to initiate phase I study of SLS-002 in patients with post-traumatic stress disorder &#40;PTSD&#41; at imminent suicide risk (suicidality).</li><li>SLS-005 (trehalose): Seelos expects to dose first patient with Sanfilippo Syndrome with Trehalose in a phase IIb trial in 2Q.</li><li>SLS-007 (Peptidic inhibitors): Seelos expects to begin to evaluate this peptide-based approach targeting the NACore (nonamyloid component core) in PD in a proof of concept, in-vivo delivery of SLS-007 in a PD transgenic mice model in 2Q.</li><li>Shares are up <font color=\"green\">33%</font> premarket.</li>                     </ul><div class=\"tiny-share-widget\" data-id=\"3446848\" data-linked=\"Seelos up 33% premarket on pipeline advancement\" data-tweet=\"$SEEL - Seelos up 33% premarket on pipeline advancement https://seekingalpha.com/news/3446848-seelos-up-33-premarket-on-pipeline-advancement?source=tweet\" data-url=\"https://seekingalpha.com/news/3446848-seelos-up-33-premarket-on-pipeline-advancement\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:02 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3446840\" data-ts=\"1553864107\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/YETI\" target=\"_blank\">YETI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3446840-yetiminus-4-after-morgan-stanley-takes-breather\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Yeti -4% after Morgan Stanley takes a breather</a></h4><ul> <li>Shares of Yeti Holdings (NYSE:<a href='https://seekingalpha.com/symbol/YETI' title='YETI Holdings, Inc.'>YETI</a>) are <font color=\"red\">down 3.77%</font> in premarket action after Morgan Stanley lowers the consumer products stock to an Equal-weight rating from Overweight.</li> <li>\"We remain constructive on YETI\u2019s long-term outlook, but now see a more balanced risk/reward,\" writes analyst Kimberly Greenberger.</li> <li>MS says it will look to upgrade the stock again if Yeti moves sharply lower.</li> <li>Yeti is up over 112% YTD and trades about 72% above where the IPO was priced.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3446840\" data-linked=\"Yeti -4% after Morgan Stanley takes a breather\" data-tweet=\"$YETI - Yeti -4% after Morgan Stanley takes a breather https://seekingalpha.com/news/3446840-yetiminus-4-after-morgan-stanley-takes-breather?source=tweet\" data-url=\"https://seekingalpha.com/news/3446840-yetiminus-4-after-morgan-stanley-takes-breather\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:55 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3446838\" data-ts=\"1553863660\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BABA\" target=\"_blank\">BABA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3446838-alibabas-lazada-heading-for-13b-gmv-baird\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Alibaba&#39;s Lazada heading for $13B GMV - Baird</a></h4><ul><li>Baird maintains Alibaba (NYSE:<a href='https://seekingalpha.com/symbol/BABA' title='Alibaba Group Holding Limited'>BABA</a>) at Outperform and raises the PT from $178 to $195 citing the Lazada subsidiary's potential.</li><li>Analyst Craig Sebastian estimates Lazada can generate $13B in gross merchandise volume this year, adding 5% to 10% to BABA's enterprise value.</li><li>Alibaba shares are <font color=\"green\">up 1.5%</font> pre-market to $180.30.</li></ul><div class=\"tiny-share-widget\" data-id=\"3446838\" data-linked=\"Alibaba&#39;s Lazada heading for $13B GMV - Baird\" data-tweet=\"$BABA - Alibaba&#39;s Lazada heading for $13B GMV - Baird https://seekingalpha.com/news/3446838-alibabas-lazada-heading-for-13b-gmv-baird?source=tweet\" data-url=\"https://seekingalpha.com/news/3446838-alibabas-lazada-heading-for-13b-gmv-baird\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:47 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3446818\" data-ts=\"1553861695\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ZEN\" target=\"_blank\">ZEN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3446818-deutsche-ups-zendesk-on-sunshine-sell-potential\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Deutsche ups Zendesk on Sunshine, Sell potential</a></h4><ul><li>Deutsche Bank raises its Zendesk (NYSE:<a href='https://seekingalpha.com/symbol/ZEN' title='Zendesk, Inc.'>ZEN</a>) price target from $88 to $94 with a Buy rating citing the potential of the Sunshine and Sell products.</li><li>The firm thinks Zendesk could do some additional product bundling after Sell is integrated, which could \"help drive continued improvements in retention\" and ARPU.</li><li>But Sunshine is \"the biggest opportunity\" in terms of growth potential.</li><li>ZEN shares are <font color=\"green\">up 1.3%</font> pre-market to $84.41.</li></ul><div class=\"tiny-share-widget\" data-id=\"3446818\" data-linked=\"Deutsche ups Zendesk on Sunshine, Sell potential\" data-tweet=\"$ZEN - Deutsche ups Zendesk on Sunshine, Sell potential https://seekingalpha.com/news/3446818-deutsche-ups-zendesk-on-sunshine-sell-potential?source=tweet\" data-url=\"https://seekingalpha.com/news/3446818-deutsche-ups-zendesk-on-sunshine-sell-potential\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:14 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3446817\" data-ts=\"1553861565\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RH\" target=\"_blank\">RH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3446817-analysts-reset-on-rh-after-soft-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Analysts reset on RH after soft guidance</a></h4><ul> <li>Deutsche Bank drop RH (NYSE:<a href='https://seekingalpha.com/symbol/RH' title='RH'>RH</a>) to a <a href=\"https://www.cnbc.com/2019/03/29/calls-of-the-day-wells-fargo-comcast-spotify-more.html\" target=\"_blank\">Hold rating</a> from Buy following the retailer's soft earnings report and guidance update.</li> <li>\"While we continue to believe in the long-term prospects for RH and acknowledge that it is one of the few retailers growing sales, margins, profit dollars and earnings, we think the market volatility means now is not the time to continue to own the stock,\" warns DB.</li> <li>\"Estimates are coming down as RH\u2019s high-end, highly discretionary product falls victim to signs of a slowing economy and stock market gyrations and weakness in high-end housing trends. In this environment, sales and profit trends have become increasingly difficult to predict for RH.\"</li> <li>Also in the mix, Bank of America Merrill Lynch lowers its price target on RH to a Street-low mark of $85.</li> <li>Shares of RH are <font color=\"red\">down 14.75%</font> in premarket trading to $112.50.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3446689-rh-scales-back-year-guidance-shares-slump-17-percent\" target=\"_blank\">RH scales back year guidance; shares slump 17%</a> (March 28)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3446817\" data-linked=\"Analysts reset on RH after soft guidance\" data-tweet=\"$RH - Analysts reset on RH after soft guidance https://seekingalpha.com/news/3446817-analysts-reset-on-rh-after-soft-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3446817-analysts-reset-on-rh-after-soft-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:12 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3446816\" data-ts=\"1553861525\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BLUE\" target=\"_blank\">BLUE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3446816-european-advisory-group-backs-bluebird-bio-gene-therapy-for-blood-disorder-shares-up-1\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">European advisory group backs bluebird bio gene therapy for blood disorder; shares up 1% premarket</a></h4><ul><li>The European Medicines Agency's advisory group CHMP has adopted a <a href=\"https://www.ema.europa.eu/en/documents/smop-initial/chmp-summary-positive-opinion-zynteglo_en.pdf\" target=\"_blank\">positive opinion</a> recommending approval for bluebird bio's (NASDAQ:<a href='https://seekingalpha.com/symbol/BLUE' title='bluebird bio, Inc.'>BLUE</a>) Lentiglobin gene therapy, branded as Zynteglo, for the treatment adolescents and adults with transfusion-dependent β-thalassaemia who do not have a β0 /β0 genotype, for whom hematopoietic stem cell transplantation is appropriate but a human leukocyte antigen &#40;HLA&#41;-matched related HSC donor is not available.</li><li>A final decision from the European Commission usually takes ~60 days.</li><li>Shares are up <font color=\"green\">1%</font> premarket on light volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3446816\" data-linked=\"European advisory group backs bluebird bio gene therapy for blood disorder; shares up 1% premarket\" data-tweet=\"$BLUE - European advisory group backs bluebird bio gene therapy for blood disorder; shares up 1% premarket https://seekingalpha.com/news/3446816-european-advisory-group-backs-bluebird-bio-gene-therapy-for-blood-disorder-shares-up-1?source=tweet\" data-url=\"https://seekingalpha.com/news/3446816-european-advisory-group-backs-bluebird-bio-gene-therapy-for-blood-disorder-shares-up-1\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:12 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3446814\" data-ts=\"1553861196\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TNP\" target=\"_blank\">TNP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3446814-tsakos-energy-eps-of-0_84\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tsakos Energy EPS of -$0.84</a></h4><ul><li>Tsakos Energy (NYSE:<a href='https://seekingalpha.com/symbol/TNP' title='Tsakos Energy Navigation Limited'>TNP</a>): Q4 EPS of -$0.84 may not be comparable to consensus of $0.00.</li><li>Revenue of $118.97M (+11.6% Y/Y) <font color=\"green\">beats by $1.33M</font>.</li><li>Shares <font color=\"green\">+1.95%</font> PM.</li><li><a href=\"https://seekingalpha.com/pr/17459607-ten-ltd-reports-fourth-quarter-profits-year-end-2018-results-declares-dividend-0_05-per\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3446814\" data-linked=\"Tsakos Energy EPS of -$0.84\" data-tweet=\"$TNP - Tsakos Energy EPS of -$0.84 https://seekingalpha.com/news/3446814-tsakos-energy-eps-of-0_84?source=tweet\" data-url=\"https://seekingalpha.com/news/3446814-tsakos-energy-eps-of-0_84\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:06 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3446812\" data-ts=\"1553861147\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TSLA\" target=\"_blank\">TSLA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3446812-jpmorgan-reels-in-estimates-on-tesla\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">JPMorgan reels in estimates on Tesla</a></h4><ul> <li>JPMorgan lowers its price target on Tesla (NASDAQ:<a href='https://seekingalpha.com/symbol/TSLA' title='Tesla, Inc.'>TSLA</a>) to $215 from $230 on concerns over Q1 delivery delays in Europe and China.</li> <li>\"Our estimate of 1Q Model 3 deliveries declines to 50,000 from 55,000 prior (and vs. current consensus of 54,590, as per the company), total deliveries go to 70,500 from 75,500 prior (vs. consensus 74,930), and adjusted EPS to $0.38 from $0.94 prior. Full-year 2019 goes to $4.25 from $4.50 and 2020 to $6.75 from $7.00.\" updates the JP analyst team.</li>  <li>The firm already had an Underweight rating on Tesla.</li> <li>Shares of Tesla are <font color=\"green\">up 0.43%</font> premarket to $279.83 vs. a 52-week trading range of $244.59 to $387.46.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3446812\" data-linked=\"JPMorgan reels in estimates on Tesla\" data-tweet=\"$TSLA - JPMorgan reels in estimates on Tesla https://seekingalpha.com/news/3446812-jpmorgan-reels-in-estimates-on-tesla?source=tweet\" data-url=\"https://seekingalpha.com/news/3446812-jpmorgan-reels-in-estimates-on-tesla\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:05 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>386&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3446805\" data-ts=\"1553860742\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KMX\" target=\"_blank\">KMX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3446805-carmaxplus-4-after-comfortable-profit-beat\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CarMax +4% after comfortable profit beat</a></h4><ul> <li>CarMax (NYSE:<a href='https://seekingalpha.com/symbol/KMX' title='CarMax, Inc.'>KMX</a>) trades higher after topping profit estimates with its <a href=\"https://seekingalpha.com/pr/17459576-carmax-reports-fourth-quarter-fiscal-year-results\" target=\"_blank\">Q4</a> report.</li> <li>Used unit sales in comparable stores increased 2.8% in Q4. The retailer says the comparable store sales performance primarily reflected improved conversion, partially offset by lower store traffic.</li> <li>Total used unit sales were up 5.6% during the quarter. Total wholesale vehicle unit sales rose 3.7%.</li> <li>CarMax management says it's pleased with the response to the omni-channel roll-out in Atlanta and notes the company is on track to have the experience available to the majority of our customers by the end of FY20.</li> <li>Looking ahead,  CarMax plans to open 13 stores in FY20 and a similar number in FY21. Capital expenditure spending is anticipated to rise to $350M in FY20 from $305M in FY19.</li> <li>KMX <font color=\"green\">+4.35%</font> premarket to $66.45 vs. a 52-week trading range of $55.24 to $81.67.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3446795-carmax-beats-0_10-misses-revenue\" target=\"_blank\">CarMax beats by $0.10, misses on revenue</a> (March 29)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3446805\" data-linked=\"CarMax +4% after comfortable profit beat\" data-tweet=\"$KMX - CarMax +4% after comfortable profit beat https://seekingalpha.com/news/3446805-carmaxplus-4-after-comfortable-profit-beat?source=tweet\" data-url=\"https://seekingalpha.com/news/3446805-carmaxplus-4-after-comfortable-profit-beat\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:59 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3446798\" data-ts=\"1553860528\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GILD\" target=\"_blank\">GILD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3446798-filgotinib-worth-much-6-share-to-gilead-leerink\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Filgotinib worth as much as $6/share to Gilead - Leerink</a></h4><ul><li>Leerink's Geoffrey Porges likes the upside of arthritis med filgotinib for Gilead Sciences (NASDAQ:<a href='https://seekingalpha.com/symbol/GILD' title='Gilead Sciences, Inc.'>GILD</a>), projecting a $5 - 6/share potential bump in value. He says the JAK1 inhibitor has an 80% (unclear how he arrived at this specific figure) chance of reaching $3.7B in peak sales (how far in the future is also unclear) considering its \"best in class\" efficacy.</li><li>Shares are up <font color=\"green\">2%</font> premarket on light volume.</li><li>Arthritis-related tickers: Galapagos NV (NASDAQ:<a href='https://seekingalpha.com/symbol/GLPG' title='Galapagos NV'>GLPG</a>); AbbVie (NYSE:<a href='https://seekingalpha.com/symbol/ABBV' title='AbbVie Inc.'>ABBV</a>); UCB (<a href='https://seekingalpha.com/symbol/UCBJF' title='UCB SA'>OTCPK:UCBJF</a>); Aclaris Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/ACRS' title='Aclaris Therapeutics, Inc.'>ACRS</a>); Eli Lilly (NYSE:<a href='https://seekingalpha.com/symbol/LLY' title='Eli Lilly and Company'>LLY</a>); Mallinckrodt (NYSE:<a href='https://seekingalpha.com/symbol/MNK' title='Mallinckrodt plc'>MNK</a>); Amgen (NASDAQ:<a href='https://seekingalpha.com/symbol/AMGN' title='Amgen Inc.'>AMGN</a>); Roche (<a href='https://seekingalpha.com/symbol/RHHBY' title='Roche Holding AG'>OTCQX:RHHBY</a>); Sanofi (NASDAQ:<a href='https://seekingalpha.com/symbol/SNY' title='Sanofi'>SNY</a>); Denali Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/DNLI' title='Denali Therapeutics Inc.'>DNLI</a>); GlaxoSmithKline (NYSE:<a href='https://seekingalpha.com/symbol/GSK' title='GlaxoSmithKline plc'>GSK</a>); Pfizer (NYSE:<a href='https://seekingalpha.com/symbol/PFE' title='Pfizer Inc.'>PFE</a>); Incyte (NASDAQ:<a href='https://seekingalpha.com/symbol/INCY' title='Incyte Corporation'>INCY</a>); Regeneron Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/REGN' title='Regeneron Pharmaceuticals, Inc.'>REGN</a>); Johnson &amp; Johnson (NYSE:<a href='https://seekingalpha.com/symbol/JNJ' title='Johnson & Johnson'>JNJ</a>)</li></ul><div class=\"tiny-share-widget\" data-id=\"3446798\" data-linked=\"Filgotinib worth as much as $6/share to Gilead - Leerink\" data-tweet=\"$GILD $GLPG $ABBV - Filgotinib worth as much as $6/share to Gilead - Leerink https://seekingalpha.com/news/3446798-filgotinib-worth-much-6-share-to-gilead-leerink?source=tweet\" data-url=\"https://seekingalpha.com/news/3446798-filgotinib-worth-much-6-share-to-gilead-leerink\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:55 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>39&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3446802\" data-ts=\"1553860307\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ACIU\" target=\"_blank\">ACIU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3446802-ac-immuneplus-3-on-new-data-on-alpha-synuclein-pet-tracer\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AC Immune +3% on new data on alpha-synuclein PET tracer</a></h4><ul> <li>AC Immune SA (NASDAQ:<a href='https://seekingalpha.com/symbol/ACIU' title='AC Immune SA'>ACIU</a>) <a href=\"https://seekingalpha.com/pr/17459424-ac-immune-presents-new-data-alpha-synuclein-pet-tracer-ad-pd-conference\" target=\"_blank\">presents</a> new data on its positron-emission tomography &#40;PET&#41; tracer, which demonstrated a high-affinity binding to human Parkinson\u2019s disease-brain derived alpha-synuclein (a-syn), potentially capable of accurately detecting and monitoring progression of Parkinson\u2019s disease &#40;PD&#41; in humans.</li><li>The Morphomer a-syn PET tracer, which is entering clinical trials for the imaging of pathological a-syn in PD and other synucleinopathies, was derived from AC Immune\u2019s proprietary small molecule Morphomer discovery platform.</li><li>Shares are up <font color=\"green\">3%</font> premarket.</li>          </ul><div class=\"tiny-share-widget\" data-id=\"3446802\" data-linked=\"AC Immune +3% on new data on alpha-synuclein PET tracer\" data-tweet=\"$ACIU - AC Immune +3% on new data on alpha-synuclein PET tracer https://seekingalpha.com/news/3446802-ac-immuneplus-3-on-new-data-on-alpha-synuclein-pet-tracer?source=tweet\" data-url=\"https://seekingalpha.com/news/3446802-ac-immuneplus-3-on-new-data-on-alpha-synuclein-pet-tracer\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:51 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3446796\" data-ts=\"1553859980\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AZN\" target=\"_blank\">AZN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3446796-astrazeneca-down-6-on-3_5b-capital-raise\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AstraZeneca down 6% on $3.5B capital raise</a></h4><ul><li>AstraZeneca (NYSE:<a href='https://seekingalpha.com/symbol/AZN' title='AstraZeneca PLC'>AZN</a>) <a href=\"https://www.astrazeneca.com/media-centre/archive/proposed-placing-of-new-ordinary-shares-release.html\" target=\"_blank\">intends</a> to raise up to ~$3.5B through a placing of new ordinary shares with both existing and new institutional investors.</li><li>Net proceeds will the fund the collaboration agreement with Daiichi Sankyo for DS-8201 announced today, the repayment of $1B, 1.95% notes due on September 18 and general corporate purposes.</li><li>Shares are down <font color=\"red\">6%</font> premarket.</li></ul><div class=\"tiny-share-widget\" data-id=\"3446796\" data-linked=\"AstraZeneca down 6% on $3.5B capital raise\" data-tweet=\"$AZN - AstraZeneca down 6% on $3.5B capital raise https://seekingalpha.com/news/3446796-astrazeneca-down-6-on-3_5b-capital-raise?source=tweet\" data-url=\"https://seekingalpha.com/news/3446796-astrazeneca-down-6-on-3_5b-capital-raise\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:46 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3446795\" data-ts=\"1553859562\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KMX\" target=\"_blank\">KMX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3446795-carmax-beats-0_10-misses-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CarMax beats by $0.10, misses on revenue</a></h4><ul><li>CarMax (NYSE:<a href='https://seekingalpha.com/symbol/KMX' title='CarMax, Inc.'>KMX</a>): Q4 GAAP EPS of $1.13 <span style=\"color:green\">beats by $0.10</span>.</li><li>Revenue of $4.32B (+5.9% Y/Y) <font color=\"red\">misses by $40M</font>.</li><li>Shares <font color=\"green\">+3.02%</font> PM.</li><li><a href=\"https://seekingalpha.com/pr/17459576-carmax-reports-fourth-quarter-fiscal-year-results\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3446795\" data-linked=\"CarMax beats by $0.10, misses on revenue\" data-tweet=\"$KMX - CarMax beats by $0.10, misses on revenue https://seekingalpha.com/news/3446795-carmax-beats-0_10-misses-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3446795-carmax-beats-0_10-misses-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:39 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3446791\" data-ts=\"1553859217\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RENN\" target=\"_blank\">RENN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3446791-renren-reports-q3-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Renren reports Q3 results</a></h4><ul><li>Renren (NYSE:<a href='https://seekingalpha.com/symbol/RENN' title='Renren Inc.'>RENN</a>): Q3 GAAP EPADS of -$0.42.</li><li>Revenue of $116.84M (+94.1% Y/Y)</li><li>Shares <font color=\"green\">+7.88%</font> PM.</li><li><a href=\"https://seekingalpha.com/pr/17459571-renren-announces-unaudited-third-quarter-2018-financial-results\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3446791\" data-linked=\"Renren reports Q3 results\" data-tweet=\"$RENN - Renren reports Q3 results https://seekingalpha.com/news/3446791-renren-reports-q3-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3446791-renren-reports-q3-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:33 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3446787\" data-ts=\"1553859002\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BB\" target=\"_blank\">BB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3446787-blackberryplus-6_6-on-q4-profit-licensing-strength\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BlackBerry +6.6% on Q4 profit, licensing strength</a></h4><ul><li>BlackBerry (NYSE:<a href='https://seekingalpha.com/symbol/BB' title='BlackBerry Limited'>BB</a>) <font color=\"green\">gains 6.6%</font> on Q4 beats with a net profit of $0.08 per share versus the $0.06 loss last year..Software and Services revenue totaled $248M (+14% Y/Y).</li><li>Guidance will come on the earnings call that starts at 8 AM ET with a webcast <a href=\"https://www.blackberry.com/us/en/company/investors\" target=\"_blank\">here</a>.</li><li>Software and Services revenue breakdown: Enterprise, $94M (consensus: $104.4M); Blackberry Tech Solutions, $55M (consensus: $55.7M); Licensing, IP &amp; Other, $99M (consensus: $78.6M).</li><li>Cash flow from operations totaled $20M with FCF at $18M.</li><li>BB ended the quarter with $1B in cash and equivalents.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3446771-blackberry-beats-0_05-beats-revenue\" target=\"_blank\">BlackBerry beats by $0.05, beats on revenue</a> (March 29)</li></ul><div class=\"tiny-share-widget\" data-id=\"3446787\" data-linked=\"BlackBerry +6.6% on Q4 profit, licensing strength\" data-tweet=\"$BB - BlackBerry +6.6% on Q4 profit, licensing strength https://seekingalpha.com/news/3446787-blackberryplus-6_6-on-q4-profit-licensing-strength?source=tweet\" data-url=\"https://seekingalpha.com/news/3446787-blackberryplus-6_6-on-q4-profit-licensing-strength\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:30 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>119&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3446784\" data-ts=\"1553858365\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SHOS\" target=\"_blank\">SHOS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3446784-comp-down-8_5-for-sears-hometown-and-outlet\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Comp down 8.5% for Sears Hometown and Outlet</a></h4><ul><li>Sears Hometown and Outlet (NASDAQ:<a href='https://seekingalpha.com/symbol/SHOS' title='Sears Hometown and Outlet Stores, Inc.'>SHOS</a>) reports comparable-store sales fell 8.5% in <a href=\"https://seekingalpha.com/pr/17459464-sears-hometown-outlet-stores-inc-reports-fourth-quarter-fiscal-year-2018-results\" target=\"_blank\">Q4</a>.</li><li>Comp for Hometown dropped 13% while Outlet rose 0.2%.</li><li>Segment sales: Hometown:$188.89M (-30.7%); Outlet sales: $109.65M (-11.1%).</li><li>SearsHometown.com sales were up 25.5% Y/Y.</li><li>Gross margin rate up 60 bps to 19.7%, primarily due to higher margin on merchandise sales in both segments.</li><li>SG&amp;A expense rate grew 110 bps to 26.5%.</li><li>Merchandise inventories slipped 17.5% to $277.29M.</li><li>Store count -223 Y/Y to 677.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3446753-sears-hometown-outlet-reports-q4-results\" target=\"_blank\">Sears Hometown and Outlet reports Q4 results</a> (March 29)</li></ul><div class=\"tiny-share-widget\" data-id=\"3446784\" data-linked=\"Comp down 8.5% for Sears Hometown and Outlet\" data-tweet=\"$SHOS - Comp down 8.5% for Sears Hometown and Outlet https://seekingalpha.com/news/3446784-comp-down-8_5-for-sears-hometown-and-outlet?source=tweet\" data-url=\"https://seekingalpha.com/news/3446784-comp-down-8_5-for-sears-hometown-and-outlet\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:19 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>26&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3446782\" data-ts=\"1553858247\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GLPG\" target=\"_blank\">GLPG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3446782-gilead-and-galapagos-up-premarket-on-positive-filgotinib-data\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Gilead and Galapagos up premarket on positive filgotinib data</a></h4><ul><li>Galapagos NV (NASDAQ:<a href='https://seekingalpha.com/symbol/GLPG' title='Galapagos NV'>GLPG</a>) and collaboration partner Gilead Sciences (NASDAQ:<a href='https://seekingalpha.com/symbol/GILD' title='Gilead Sciences, Inc.'>GILD</a>) are up <font color=\"green\">14%</font> and <font color=\"green\">2%</font>, respectively, premarket on light volume on the heels of <a href=\"https://seekingalpha.com/pr/17459263-gilead-galapagos-announce-filgotinib-meets-primary-endpoint-phase-3-finch-3-study\" target=\"_blank\">successful results</a> from a Phase 3 clinical trial, <a href=\"https://clinicaltrials.gov/ct2/show/NCT02886728?term=finch+3&amp;rank=1\" target=\"_blank\">FINCH 3</a>, evaluating JAK1 inhibitor filgotinib in adults with moderately-to-severely active rheumatoid arthritis &#40;RA&#41;.</li><li>The study met the primary endpoint of a statistically significant proportion of patients treated with filgotinib + methotrexate &#40;MTX&#41; achieving ACR20 (20% improvement in RA symptoms) at week 24 compared to MTX alone.</li><li>Specifically, 81.0% of patients receiving 200 mg of filgotinib + MTX, 80.2% of those receiving 100 mg of filgotinib + MTX and 78.1% of those receiving 200 mg of filgotinib alone achieved ACR20 compared to 71.4% of those receiving MTX alone. The separations in the two filgotinib + MTX arms were statistically significant, but the filgotinib monotherapy arm was not.</li><li>The proportions of patients in the three arms achieving ACR70 (70% improvement in RA symptoms) were 43.8%, 40.1% and 40.0%, respectively, compared to 26.0% for MTX alone. All were statistically significant.</li><li>No new safety signals were observed.</li><li>Detailed data will be submitted for presentation at a future scientific conference.</li></ul><div class=\"tiny-share-widget\" data-id=\"3446782\" data-linked=\"Gilead and Galapagos up premarket on positive filgotinib data\" data-tweet=\"$GLPG $GILD - Gilead and Galapagos up premarket on positive filgotinib data https://seekingalpha.com/news/3446782-gilead-and-galapagos-up-premarket-on-positive-filgotinib-data?source=tweet\" data-url=\"https://seekingalpha.com/news/3446782-gilead-and-galapagos-up-premarket-on-positive-filgotinib-data\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:17 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>18&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3446781\" data-ts=\"1553858186\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NIO\" target=\"_blank\">NIO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3446781-nio-plays-defense-against-chinese-ev-rivals\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nio plays defense against Chinese EV rivals</a></h4><ul> <li>NIO (NYSE:<a href='https://seekingalpha.com/symbol/NIO' title='NIO Inc.'>NIO</a>) has <a href=\"https://www.reuters.com/article/us-nio-banks-exclusive/exclusive-chinese-ev-car-maker-nio-restricts-its-ipo-banks-from-working-for-rivals-sources-idUSKCN1RA122?feedType=RSS&amp;feedName=businessNews\" target=\"_blank\">handcuffed</a> the eight investment banks that worked on its IPO by making them sign year-long non-compete clauses, sources tell Reuters.</li> <li>The rare move precludes Bank of America Merrill Lynch, Citigroup, Credit Suisse, Deutsche Bank, Goldman Sachs, JPMorgan, Morgan Stanley and UBS from raising public or private funds for Nio rivals for 12 months.</li> <li>Xpeng Motors, WM Motor and Byton are three of the Chinese EV companies said to be on the restricted list of Nio rivals.</li> <li>Shares of Nio are <font color=\"green\">up 1.20%</font> in premarket trading to $5.07.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3446781\" data-linked=\"Nio plays defense against Chinese EV rivals\" data-tweet=\"$NIO - Nio plays defense against Chinese EV rivals https://seekingalpha.com/news/3446781-nio-plays-defense-against-chinese-ev-rivals?source=tweet\" data-url=\"https://seekingalpha.com/news/3446781-nio-plays-defense-against-chinese-ev-rivals\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:16 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>36&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3446780\" data-ts=\"1553857820\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MITK\" target=\"_blank\">MITK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3446780-mitek-worth-18_50-20-in-takeout-benchmark\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Mitek worth $18.50-$20 in takeout - Benchmark</a></h4><ul><li>Mitek Systems (NASDAQ:<a href='https://seekingalpha.com/symbol/MITK' title='Mitek Systems, Inc.'>MITK</a>) could see $18.50 to $20 per share in a a potential takeout, according to Benchmark analyst Mark Schappel.</li><li>The analyst sees the takeout value as \"considerably\" higher than the current market cap and estimates the firm value at $15.44 per share.</li><li>The lower end of his range assumes a \"conservative\" 20% takeout premium.</li><li>Mitek shares are <font color=\"green\">up 4.3%</font> pre-market to $12.26.</li></ul><div class=\"tiny-share-widget\" data-id=\"3446780\" data-linked=\"Mitek worth $18.50-$20 in takeout - Benchmark\" data-tweet=\"$MITK - Mitek worth $18.50-$20 in takeout - Benchmark https://seekingalpha.com/news/3446780-mitek-worth-18_50-20-in-takeout-benchmark?source=tweet\" data-url=\"https://seekingalpha.com/news/3446780-mitek-worth-18_50-20-in-takeout-benchmark\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:10 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3446771\" data-ts=\"1553857354\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BB\" target=\"_blank\">BB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3446771-blackberry-beats-0_05-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BlackBerry beats by $0.05, beats on revenue</a></h4><ul><li>BlackBerry (NYSE:<a href='https://seekingalpha.com/symbol/BB' title='BlackBerry Limited'>BB</a>): Q4 Non-GAAP EPS of $0.11 <span style=\"color:green\">beats by $0.05</span>; GAAP EPS of $0.08.</li><li>Revenue of $257M (+7.5% Y/Y) <font color=\"green\">beats by $14.19M</font>.</li><li>Shares <font color=\"green\">+6.4%</font> PM.</li><li><a href=\"https://seekingalpha.com/pr/17459545-blackberry-reports-record-software-services-revenue-fourth-quarter-fiscal-year-2019\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3446771\" data-linked=\"BlackBerry beats by $0.05, beats on revenue\" data-tweet=\"$BB - BlackBerry beats by $0.05, beats on revenue https://seekingalpha.com/news/3446771-blackberry-beats-0_05-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3446771-blackberry-beats-0_05-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:02 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>18&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3446768\" data-ts=\"1553856402\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NBEV\" target=\"_blank\">NBEV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3446768-new-age-beverages-misses-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">New Age Beverages misses on revenue</a></h4><ul><li>New Age Beverages (NASDAQ:<a href='https://seekingalpha.com/symbol/NBEV' title='New Age Beverages Corporation'>NBEV</a>): Q4 Adjusted EBITDA of -$4.5M</li><li>Revenue of $14M (+25.0% Y/Y) <font color=\"red\">misses by $0.6M</font>.</li><li>Shares <font color=\"green\">+5.37%</font> PM.</li><li><a href=\"https://seekingalpha.com/pr/17459511-new-age-beverages-corporation-announces-4th-quarter-revenue-growth-24-percent-increase-pro\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3446768\" data-linked=\"New Age Beverages misses on revenue\" data-tweet=\"$NBEV - New Age Beverages misses on revenue https://seekingalpha.com/news/3446768-new-age-beverages-misses-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3446768-new-age-beverages-misses-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:46 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>34&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3446767\" data-ts=\"1553856214\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DWDP\" target=\"_blank\">DWDP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3446767-sales-forecast-cut-weighs-on-dowdupont-shares\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sales forecast cut weighs on DowDupont shares</a></h4><ul><li>DowDuPont (NYSE:<a href='https://seekingalpha.com/symbol/DWDP' title='DowDuPont Inc.'>DWDP</a>) <font color=\"red\">-2.5%</font> premarket after <a href=\"https://www.reuters.com/article/us-dowdupont-outlook/dowdupont-cuts-sales-forecast-as-midwest-floods-hit-agri-division-idUSKCN1R92RR\" target=\"_blank\">cutting</a> its forecast for Q1 sales, citing the impact of U.S. Midwest floods on its agri business as well as weakness in its packaging and specialty plastics division.</li><li>Sales from its agri business are expected to be down 4%-6% and operating EBITDA is expected to be down by $125M-$150M.</li><li>DowDupont also forecast a $100M reduction in its materials science division\u2019s operating EBITDA due to lower margins in packaging and specialty plastics globally.</li></ul><div class=\"tiny-share-widget\" data-id=\"3446767\" data-linked=\"Sales forecast cut weighs on DowDupont shares\" data-tweet=\"$DWDP $DD $DOW - Sales forecast cut weighs on DowDupont shares https://seekingalpha.com/news/3446767-sales-forecast-cut-weighs-on-dowdupont-shares?source=tweet\" data-url=\"https://seekingalpha.com/news/3446767-sales-forecast-cut-weighs-on-dowdupont-shares\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:43 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>22&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":74,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}